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ABSTRACT 
Objective: Irritable Bowel Syndrome (IBS) is the most commonly diagnosed 
Gastrointestinal (GI) condition in the United States affecting 30 million (10%) people. 
Symptoms include abdominal pain, bloating, distension, excessive wind and altered 
bowel habits when anatomical abnormalities and inflammation have been excluded. A 
low-FODMAP diet is now considered as an effective strategy for managing symptoms of 
IBS in Australia, with interest expanding across the world. Several limitations of a low-
FODMAP diet pertaining to dietary quality and health benefits have been suggested. 
Malabsorbed FODMAPs provide multiple benefits which include a natural laxative effect 
due to their osmotic effects, a prebiotic effect with beneficial fermentation by-products 
and production of a low glycemic response compared to other carbohydrates. 
Additionally, Dietary adherence is crucial to the success of a low-FODMAP diet, 
however most people do not find the diet easy to incorporate into their life. Not one study 
has looked exclusively at healthy adults or looked at changes in FODMAP intake and diet 
quality as compared to established guidelines. A study is needed looking at dietary 
quality of low- vs. high-FODMAP diets and should consider how adherence and other 
factors that may influence efficacy of the diet. 
Design: This study used a single-blinded crossover design. Subjects (n=16) were 
instructed about following a low-FODMAP and a high-FODMAP diet for three days 
each, presented in a random order and separated by an 11-day wash out period. The study 
was entitled “The Carb Study” and diets labeled “diet 1” and “diet 2” without reference 
to FODMAP. No food was provided. Dietary instruction was provided for each diet along 
  
with a dietary booklet. Dietary assessment consisted of four 24-hour recalls using NDS-
R. Recalls assessed the day prior to each intervention period (2 baselines) and assessed 
day 3 of each intervention period (2 interventions). FODMAP intake was estimated based 
on the sum of fructose, lactose and polyol intake and dietary quality was calculated based 
on the Healthy Eating Index 2010 (HEI-2010). 
Setting: Free living subjects recruited from a northeastern university. 
Subjects: Participants were healthy adults without gastrointestinal disorders (n=16, 63% 
female, 20.47±1.77 years). 
Results: There was no effect of diet order. There was a non-significant trend for a 
between treatment difference in FODMAP intake (F(1,14df)=4.27, p=.058) and a significant 
difference between groups in HEI-2010 total score (F(1,14df)=10.45, p=.001). Within the 
low-FODMAP treatment, FODMAP intake decreased from 36.30±22.62 grams to 
19.29±15.79 grams (-t=2.84, p=.01) and HEI-2010 scores increased from 53.60±17.16 to 
63.09±17.23 (t=2.20, p=.04); Energy intake also significantly decreased from 2259±1325 
kcals to 1510±795 kcals (-t=2.68, p=.017). Within the high-FODMAP treatment, there 
was no change in FODMAP intake (t=.35, p=.731) but HEI-2010 scores decreased from 
60.83±12.76 to 52.04±11.27 (-t=2.45, p=.027); There was no difference in energy intake 
(1993±962 to 2251± 864, -t=1.57, p=.14) 
Conclusions:  This study suggests that reducing FODMAP is feasible in healthy, free-
living young adults and that this reduction is associated with an increase in dietary 
quality. However, the high-FODMAP intervention in this study was not effective in 
increasing FODMAP intake. Future research with larger samples is needed to develop 
interventions for increasing healthy FODMAP intake in young adults. In addition, future 
  
research is needed to assess long-term effects of these dietary modifications in healthy 
individuals.  
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Effect of High- and Low-FODMAP Diet Instruction on FODMAP Intake and 
Dietary Quality in Healthy Young Adults 
  
James M. O’Toole, Geoffrey W. Greene, Colleen A. Redding and Kathleen J. Melanson 
Department of Nutrition and Food Sciences, University of Rhode Island 
Kingston, Rhode Island 02881 
 
ABSTRACT 
Objective: The purpose of this study was to investigate the effects of dietary instruction 
for low- and high-FODMAP diets on FODMAP intake and dietary quality in healthy 
young adults.  
Design: This study had a single-blinded crossover design. Subjects (n=16) were 
instructed about following a low-FODMAP and a high-FODMAP diet for three days 
each, presented in a random order and separated by an 11-day wash out period. The study 
was entitled “The Carb Study” and diets were labeled “diet 1” and “diet 2” without 
reference to FODMAP. No food was provided. Dietary instruction was provided for each 
diet along with a dietary booklet. Dietary assessment consisted of four 24-hour recalls 
reflecting the day prior to each intervention period (2 baselines) and assessed day 3 of 
each intervention period (2 interventions). FODMAP intake was estimated based on the 
sum of fructose, lactose and polyol intake and dietary quality was calculated based on the 
Healthy Eating Index-2010 (HEI-2010). 
Setting: Free living subjects were recruited from a northeastern university. 
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Subjects: Participants were healthy young adults without gastrointestinal disorders 
(n=16, 63% female, 20.47±1.77 years). 
Results: There was no effect of diet order. There was a non-significant trend for a 
between treatment difference in FODMAP intake (F(1,15df)=4.27, p=.06), but a significant 
difference between treatment groups in HEI-2010 total score (F(1,14df)=10.45, p=.001). 
Within the low-FODMAP treatment, FODMAP intake decreased from 36.30±22.62 
grams to 19.29±15.79 grams (-t=2.84, p=.01) and HEI-2010 scores increased from 
53.60±17.16 to 63.09±17.23 (t=2.20, p=.04); Energy intake also significantly decreased 
from 2259±1325 kcals to 1510±795 kcals (-t=2.68, p=.017). Within the high-FODMAP 
treatment, there was no change in FODMAP intake (t=.35, p=.73) but HEI-2010 scores 
decreased from 60.83±12.76 to 52.04±11.27 (-t=2.45, p=.027); There was no difference 
in energy intake (1993±962 to 2251± 864, -t=1.57, p=.14)  
Conclusions:  This study suggests that reducing FODMAP is feasible in healthy, free-
living young adults and that this reduction is associated with an increase in dietary 
quality. Long term studies are needed to confirm these results. The high-FODMAP 
intervention used in this study was not effective in increasing FODMAP intake. Future 
research with larger, more diverse samples is needed to develop interventions for 
increasing healthful FODMAP intake in young adults. In addition, future research is 
needed to assess long-term effects of these dietary modifications in healthy individuals.  
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1. INTRODUCTION 
 In 2005 at Monach University in Australia, the term FODMAP (fermentable 
oligo-, di-, mono-saccharides and polyols) was coined to identify a group of poorly 
absorbed short-chain carbohydrates (CHO) that when ingested in excess, or when 
consumed by individuals with bowel disorders, can induce the gastrointestinal (GI) 
symptoms of abdominal pain, bloating, distension, flatulence and diarrhea 
12
. These CHO 
are widespread in the diet 
1
 and include the oligosaccharides fructooliogosaccharides 
(fructans or FOS) and galactooligosaccharides (GOS), the disaccharide lactose, the 
monosaccharide fructose and all sugar alcohols (polyols) 
2
. FODMAPs have three 
common functional properties. They are 1) poorly absorbed in the proximal small 
intestine, allowing substrate to reach the distal small intestine and proximal colon 2) 
small and osmotically-active, increasing the liquidity of luminal content due to osmosis 
and 3) rapidly fermented by gut microbiota, increasing the amount of gas in the colon 
1
. 
These characteristics combine to increase luminal distension, the physiological basis for 
the genesis of many GI symptoms 
1
. 
 It is hypothesized that GI symptoms are created primarily by luminal distention
3
 
creased by fermentation and osmosis 
4
. Studies have concluded that high-FODMAP diets 
induce GI symptoms 
5,6
, and low-FODMAP diets relieve GI symptoms associated with 
functional GI disorders 
7-10
 with GI symptoms returning when FODMAPs are 
reintroduced into the diet 
11
. Overall GI symptoms have been seen in up to 86% of 
Irritable Bowel Syndrome (IBS) patients 
7
. Accordingly, a low-FODMAP diet has been 
recommended for managing GI symptoms for IBS patients
12
. Applications are expanding 
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to enteral feeding formulas 
13
, a low-FODMAP diet for patients with non-celiac gluten 
sensitivity
14
 and the treatment of infantile colic 
15
.  
 A first consideration for FODMAP diets is the overall quality and adequacy of 
the diet, as well as associated health benefits. FODMAPs are CHO or related polyols 
found in fruits, vegetables, legumes, wheat and other grain products as well as milk and 
dairy products. A FODMAP restricted diet limits the available options in these nutrient-
dense food groups. Additionally, in all populations FODMAPs are malabsorbed 
16-20
. 
Malabsorbed CHO can provide a prebiotic effect due to fermentation by-products 
12
 and 
CHO products high in FODMAPs tend to generate a lower glycemic response compared 
to CHO products lower in FODMAPs 
21
. A low-FODMAP diet may adversely affect gut 
microflora and compromise fiber intake 
12
 and dietitians instructing patients on low-
FODMAP diet should provide options for high-fiber alternative fruits, vegetables and 
grains as well as adequate sources of calcium and vitamin D 
4,16,22
. There is limited 
evidence comparing the effect of low- vs. high-FODMAP diets on fiber or any other 
nutrient intake 
12
. One retrospective study found limited differences in macronutrient 
intake comparing current diets of free-living subjects who had received low-FODMAP 
dietary advice two years previously to healthy controls 
23
.  
 Another consideration for FODMAP diets is dietary adherence.  Adherence 
appears to be crucial to the success of a low-FODMAP diet with correlations between 
adherence and symptom improvement reported 
8
.  Most people do not find the diet easy 
to incorporate into their life 
8,10
, although controlled studies with IBS patients have shown 
high adherence rates both when all foods are provided 
11
 and when provided with dietary 
advice 
8
. Potential barriers to adherence include buying the appropriate food
10
, 
6 
 
implementing the diet
8,10
, following the diet
8
 and taste 
8,10
. There is limited research 
available about following a high-FODMAP diet, but individuals are likely to face barriers 
given the presence of adverse GI symptoms
5,6
.  
    The primary aim of this study was to investigate the effect of dietary instruction 
on implementing low- and high-FODMAP diets on FODMAP intake as well as on 
dietary quality in healthy, free living, young adults. Secondary aims were to investigate 
changes in mood, GI symptoms and subjects’ opinions regarding the diet, as potential 
variables that may impact dietary adherence.  
 
2. METHODS 
2.1 Subjects 
 Twenty healthy, young adults, free from GI disorders were enrolled in this 
study. Four subjects withdrew from this study, one for medical conditions unrelated to 
the study and three failed to compete any assessments beyond baseline. Thus 16 subjects 
completed the study and were considered the study sample. Exclusionary GI disorders 
included celiac disease, IBS, lactose or gluten intolerance, diverticular disease, colitis 
such as Crohn’s disease or ulcerative colitis and stomach ulcers. Additional exclusion 
criteria included currently following a weight loss diet, food allergies, smoking, 
pregnancy or lactation, diabetes, adrenal disease, kidney or bladder problems, a thyroid 
disease or currently taking any appetite suppressant medication. All subjects were 
recruited via classroom announcements at the University of Rhode Island or emails sent 
to adults who were candidates/participants in previous, nutrition-related studies. Subjects 
received a $80 stipend for completing the study. The study was approved by the 
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Institutional Review Board of the University of Rhode Island and subjects provided 
written informed consent prior to participating. 
2.2 Study Design 
The study was a randomized, single-blinded, cross-over study that compared two 
diet-interventions in a free-living setting; instruction on low- vs. high-FODMAP diet. In 
order to ensure that the diets were single-blinded, the study was entitled “The Carb 
Study” and the two interventions were labeled “Diet 1” and “Diet 2” representing the 
low-FODMAP diet and high-FODMAP diet respectively. No food was provided. Each 
intervention had a corresponding diet instruction booklet that was developed specifically 
for this project with foods identified as either high- or low in FODMAPs at the time of 
the study
1,5,7,23-25
. Subjects were provided with 15-minute instructions about each dietary 
treatment and asked to follow this booklet to the best of their ability for each three day 
intervention period.  
 An initial screening was conducted to verify potential participants met inclusion 
criteria. Body fat percentage was assessed using the BOD POD Body Composition 
System (Life Measurement Instruments, Concord, Calif., USA).  Subjects where then 
randomized to start with either the low-FODMAP diet (order 1) or the high-FODMAP 
diet (order 2). Each dietary period was followed by an eleven day wash out period where 
subjects consumed their normal diet. Following the wash out period, subjects completed 
the remaining dietary intervention. Each intervention lasted three days: Tuesday, 
Wednesday, and Thursday.  
 Four 24 hour recalls were conducted with each subject. At the start of each dietary 
intervention period on Tuesday, each 24-hour recall measured dietary intake on Monday 
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(baseline).  After completion of each intervention period on Friday, each recall measured 
intake on Thursday (intervention). FODMAP intake, Healthy Eating Index-2010 (HEI-
2010) scores, and intake of other selected nutrients were obtained from these 24 hour 
recalls. Subjects also completed questionnaires on Fridays of each intervention period 
assessing mood and GI symptoms. An additional “opinion regarding the diet” 
questionnaire was filled out by a convenience sample of subjects at the end of each 
intervention period. 
2.3 Dietary Instructions and Diet Booklet 
 At the baseline visit for each diet, subjects met with a trained research assistant 
who provided each subject with a 16 page diet instruction booklet. The booklets 
contained a detailed list of recommended and restricted foods corresponding to either the 
low-FODMAP diet or the high-FODMAP diet. A brief, 15 minute diet instruction session 
was provided, which included identifying encouraged and discouraged foods, tips, and 
emphasized the importance of adhering to the diet for research purposes. 
2.4 NDSR 24 Hour Food Recall 
 As described above, four in-person 24 hour recalls were conducted by trained 
research assistants. Recalls were conducted using the Nutrition Data System for Research 
(NDS-R) software version 12 developed by the Nutrition Coordinating Center (NCC), 
University of Minnesota, Minneapolis. NDS-R utilizes a multiple pass method described 
in full elsewhere 
26
. Briefly, pass one included obtaining a quick list of foods consumed 
in the past 24 hours. In pass two, participants were asked to produce details regarding 
foods on their quick list including portion sizes and amounts eaten. In pass three the list 
was recited and participants are asked if any information was forgotten. Food amount 
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booklets distributed by the NCC as well as food models were available during food 
recalls in order to assure accurate portion sizes.  
  Foods that were not in the NDS-R database were listed as “missing foods” and 
resolved after the interview was completed. Resolution of a missing food required finding 
an NDS-R substitute (similar food or a generic version of a food) in the database and 
matching that substitute for CHO, protein, fat and kcal. Matching was defined as within 
1-3 grams for each macronutrient and within 10 kcals for energy. For some foods, the 
potential FODMAP content was considered too variable for application of the normal 
missing food substitution protocol (for example ice cream brands and artificially 
sweetened beverages).  These foods were sent to the NCC, who provided an accurate 
nutrient breakdown for those items.  
2.5 FODMAP intake 
 NDS-R output files were used to sum total intake (g) of fructose, lactose and the 
polyols (erythritol, inositol, isomalt, lactitol, maltitol, mannitol, pinitol, sorbitol and 
xylitol). These items were used to estimate FODMAP intake. Because NCC does not 
calculate consumption of galacto-oligosaccharides or fructo-oligosaccharides (GOS or 
FOS), estimated FODMAP intake underestimates total FODMAP intake and FODMAP 
in this study was defined based on the available FODMAP items. Although 
oligosaccharide intake is difficult to estimate, intake of FOS may vary from 3-13 g/day in 
western countries 
27
. 
2.6 Dietary Quality: Healthy Eating Index 2010 
 From NDS-R output files, The Healthy Eating Index 2010 (HEI-2010) 
28
 was 
calculated. The Healthy Eating Index is a measure of dietary quality assessing how well 
10 
 
an individual’s diet compares with Dietary Guidelines for Americans 2010 (DGA) 29. The 
total HEI score ranges from 0 (low) to 100 (high). The total score is based on eight 
“adequacy” components: total fruit, whole fruit, total vegetables, greens and beans, whole 
grains, dairy, total protein foods, seafood and plant proteins as well as four “moderation” 
components: fatty acids, refined grains, sodium, and empty calories 
29
. Intake is in energy 
adjusted per 1,000 kcal.  
 Calculation of the HEI-2010 for this study was based on a protocol developed by 
the NCC based on methods described in a previous study 
30
. The calculations were made 
using Microsoft Excel, 2007 and performed twice to check accuracy. 
2.7 Assessment of mood state and gastrointestinal symptoms 
 All subjects completed two questionnaires regarding their mood state and GI 
symptoms prior to bed on the final day of each intervention. The mood questionnaire 
used 10-cm VAS response scale anchored at each end “0=Very Little” and “10=Very 
Much” that had been used in a previous study 31.The 10 items included: how alert do you 
feel, how sad do you feel, how tense do you feel, how much of an effort is it to do 
anything, how happy do you feel, how weary do you feel, how calm do you feel, and how 
sleepy do you feel. The symptoms questionnaire was a 3-item scale with a similar VAS 
response scale based on scales used with IBS patients. Items included: how severe is your 
abdominal pain, how severe is your abdominal distention/tightness, and how satisfied are 
you with your bowel movements.  
2.8 Opinion regarding the diet 
 Following each intervention 24 hour recall, a convenience sample completed a 4-
item evaluation of the diet using with a 10-cm VAS response scale from previous 
11 
 
FODMAP-related studies 
8,10,11
. Items included: how easy/difficult had it been to 
implement the diet, how easy/difficult had it been to adhere to the diet, how easy/difficult 
was it to obtain the appropriate food, how would you rank the overall taste.  
2.9 Statistics  
 Statistical analyses were performed using SPSS, version 22.0 (IBM Corporation, 
Summers, NY, USA). All variables met criteria for normality.  Baseline comparisons 
between subjects assigned to the two orders were conducted using t-tests and χ2 tests.  
Primary outcomes (grams of FODMAP and HEI-2010 scores) were assessed using 
separate 2 (treatment) x 2 (time) x 2 (order) mixed factorial ANOVA followed by within-
treatment paired t-tests (baseline and intervention). The η2 was calculated to estimate 
effect size using Cohen’s categories of small (.10), medium (.25) and large (.40) 32. 
Energy intake (kcal/day) was assessed using similar analyses.  All other inferential 
analyses of dietary components were performed using a 2 x2 repeated measures ANOVA 
where the independent variables were treatment (low- vs. high-FODMAP) and time 
(baseline vs. intervention). Paired t-tests compared mood, symptoms and compliance 
factors between treatments and Pearsons bivariate correlations explored relationships 
between variables. Median scores were reported for diet opinion. P < .05 was considered 
statistically significant. 
 
3. RESULTS 
 There were no differences in demographic variables between subjects assigned to 
the two orders. Mean age of the 16 subjects was 20.6 years (range 18-23) and 10 were 
female.  Further information is presented in Table 1.  
12 
 
 Values for FODMAP intake and all dietary data including both the total and 
subscales of the HEI-2010 did not differ at baseline between the two orders. 
 There were non-significant trends for grams of FODMAP per day for time 
(F(1,14df)=4.38, p=.06, η
2=.24) and time*treatment(F(1,14df)= 4.27, p=.06 η
2=.23), but no 
main effect of order (F(1,14df)=.17, p=.68, = η
2
.01) or time*treatment*order interaction 
(F(1,14df)=.33, p=.57, = η
2
.02). Within treatments, FODMAP intake decreased in the low-
FODMAP treatment (36.30±22.62 grams to 19.29±15.79 grams, t=2.84, p=.01) but there 
was no change in the high-FODMAP treatment (35.93±18.08 grams to 34.04±13.72 
grams, t=.35, p=.73) (Figure 1).  
 HEI-2010 scores are listed in Table 2. For total HEI-2010, there was no main 
effect of order (F(1,14df)=.16, p=.70, = η
2
.01), and no treatment*time*order interaction 
F(1,14df)=.32, p=.58, η
2
=.02. There was no main effect for time (F(1,14df)=.02, p=.90, 
η2=.00), there was a treatment*time interaction (F(1,14df)=10.45, p=.006, η
2
=.43) with a 
large effect size
32
. Within treatments, total HEI-2010 scores increased during the low-
FODMAP treatment and decreased during the high-FODMAP treatment. When 
comparing values during the treatment periods, there was a higher total HEI-2010 score 
in the low-FODMAP treatment compared to the high-FODMAP treatment (63.09±17.23 
vs. 52.04±11.27; t=2.40, p=.03). 
 HEI-2010 component scores are presented in Table 2. No time*treatment 
interactions were found for any component scores. There was a main effect of time for 
the total protein score, (F(1,15df)=4.66, p=.048, η
2
=.24) and sodium score (F(1,15df)= 4.92, 
p=.042, η2=.25).Within treatments, there was an increase in protein score during the low-
FODMAP treatment but no change in the high-FODMAP treatment and a decrease in 
13 
 
sodium score indicating an increase in sodium intake in the high-FODMAP treatment 
with no change in the low-FODMAP treatment.  Because HEI-2010 component scores 
are energy adjusted and there was a change in energy intake (see next paragraph), non-
energy adjusted component scores were calculated.  There were time*treatment 
interactions for total refined grains (F(1, 15df)= 10.56, p=.005, η
2
=.41) and total empty 
calories (F(1,15df)= 8.02, p=.013, = η
2
=.35 ).Within treatment analyses found a decrease in 
refined grains during the low-FODMAP treatment (6.47±4.65 oz to 2.79±3.46 oz, t=3.63, 
p=.002) and no change during the high-FODMAP treatment (5.59±4.62 to 7.20± t=4.63, 
p=.13) and a decrease in empty calories in the low-FODMAP treatment (620.02±455.62 
kcal to 342.08±283.96 kcal, t=2.64, p=.02) with no change in the high-FODMAP 
treatment (552.56±445.97 to 610.49±411.47, t=-.77, p=.46)  
 Macro- and micronutrient information is presented in Table 3. The primary 
analysis was a time*treatment*order ANOVA for energy intake. There was no main 
effect of order (F(1,14df)=0.66, p=.43, η
2
=.05), and no treatment*time*order interaction 
(F(1,14df)=0.03, p=.87, η
2
=.00). There was no main effect of time (F(1,14df)=2.24, p=.16, 
η2=.14). There was a significant treatment*time interaction for energy intake 
(F(1,14df)=8.62, p=.01, η
2
=.40) with a large effect size. Within treatments, energy intake 
decreased in the low-FODMAP condition but did not change in the high-FODMAP 
condition. Looking at specific macronutrients, the most variability came in the 
carbohydrate variables. There was a significant treatment*time interaction for total 
carbohydrate intake in grams, (F(1,14df)=6.28, p=.02), lactose intake in grams, 
(F(1,15df)=5.20, p=.04), calcium intake in mg, (F(1,15df)=4.65, p=.048) and sodium intake in 
mg, (F(1,15)=9.98, p=.006). Within treatments there was a decrease in total carbohydrates 
14 
 
in the low-FODMAP treatment but no change in the high-FODMAP treatment.  Lactose 
intake decreased during the low-FODMAP treatment and did not change in the high-
FODMAP treatment.  Sodium intake did not change in the low-FODMAP treatment and 
increased in the high-FODMAP treatment. Calcium intake did not change in either 
treatment, but there was a significant time*treatment interaction, F(1, 15df)= 4.64, p=.048, 
η2=.24.  
 There were no differences in mood score between conditions except “how weary 
do you feel” was significantly higher in the low-FODMAP treatment than the high-
FODMAP treatment (5.86 vs. 3.88, t=2.89, p=.01).There were no differences in 
symptoms, however, both abdominal pain and distention had extremely low mean scores 
(less than 1) for both treatments and satisfaction with bowel movements did not differ 
between treatments (6.29±1.56 vs. 6.36±2.44, t=.13, p=.90).  
 At the end of each intervention period, a convenience sample of subjects (low-
FODMAP n=9, high-FODMAP n=7) were asked about their diets. For the low-FODMAP 
diet, more subjects found it difficult to implement the diet (6.4±2.1 vs. 4.8±2.8) and 
adhere to the diet (5.7±1.9 vs. 4.6±2.4) and ranked the taste poorly (4.6±2.4 vs. 7.0±1.5) 
compared to the high-FODMAP diet.  
 
4. DISCUSSION  
4.1 Summary 
 The purpose of this study was to investigate the effects of dietary instruction for 
low- and high-FODMAP diets on dietary quality and FODMAP intake in healthy young 
adults.  We found that the low-FODMAP diet resulted in an increase in dietary quality 
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with a reduction in FODMAP intake. The high-FODMAP diet had no effect on 
FODMAP intake while dietary quality decreased. This was the first FODMAP study to 
the researchers’ knowledge that looked at changes in dietary quality when implementing 
FODMAP diets and indicated that a low-FODMAP diet may have a positive impact on 
diet quality. Future studies should also consider this diet’s effect on weight change given 
the substantial energy decrease observed here. 
 Another strength of this study was the use of the HEI-2010. The HEI-2010 is a 
valid and reliable measure of dietary quality 
33
 in conformance with the 2010 Dietary 
Guidelines for Americans (DGA) 
28
. (The HEI utilizes set energy density standard (per 
1000 kcals) 
28
, important since a large difference in energy intake was found). The mean 
HEI-2010 scores in this study were higher than for the average U.S. adult, 20-30 years of 
age (45.4±1.1) 
33
 but similar to past studies at the University of Rhode Island 
34
. 
 The high-FODMAP intervention did not affect FODMAP intake. During the 
high-FODMAP intervention, no food was completely prohibited like foods were during 
the low-FODMAP intervention. Instead, low-FODMAP foods were “discouraged” and 
high-FODMAP foods were “encouraged”. Future studies should test other types of high-
FODMAP dietary instructions. A more effective possible future strategy could be to 
prescribe a set number of servings of foods on the high-FODMAP diet per meal. Future 
research is needed to develop interventions for increasing healthful FODMAP intake in 
young adults. 
4.2 Subjects 
 Healthy young adults free of any GI disorders were included in this study. To 
the researchers’ knowledge, this is the only FODMAP study that has looked exclusively 
16 
 
at healthy adults. Previous FODMAP focused on populations with IBS 
5-10
. In one of the 
few FODMAP studies that included healthy adults, Ong et al.
5
 compared healthy adults 
(n=15) to IBS patients (n=15) and compared high-FODMAP conditions (50g/day) to low-
FODMAP conditions (9 g/day) during a two day intervention. The study was a single-
blinded crossover intervention comparing low- vs. high-FODMAP conditions in which 
all foods were provided for two days. The study found that a high-FODMAP diet had no 
effect on symptoms except for increased flatulence in healthy adults. Similarly, our study 
found that both abdominal pain and distention were not factors in this population 
however we did not assess flatulence.  
4.3 The effect of a low-FOMAP diet on Dietary Quality 
 Due to the restriction of fruits, vegetables, dairy and legumes, dietary quality 
was hypothesized to decrease on the low-FODMAP diet, whereas the opposite occurred. 
Looking at the change in dietary quality, the low-FODMAP intervention was most 
effective at restricting refined products and “empty calories” including solid fat, added 
sugar and sodium-rich foods. This restriction contributed to the large decrease in energy 
and carbohydrate intake. These results indicate that a low-FODMAP diet has potential to 
have a positive influence on dietary quality in college students but future studies are 
needed with adults showing more dietary diversity. The implications of the decrease in 
energy intake should be examined in future research. 
 To the researchers’ knowledge this was the first FODMAP study that examined 
dietary quality in healthy adults. Ostgaard et al. 
23
 examined diet composition of IBS 
patients who received low-FODMAP education (guided n=43) two years prior. This 
study showed no difference between the guided and control group for calories, CHO, 
17 
 
protein, fat, sugars or fiber intake and did not measure dietary quality. This study used 
food frequency questionnaires (FFQ) to measure nutrient intakes as opposed to our study 
which used 24 hour food recalls.  
4.4 The effect of a low-FODMAP diet on other health benefits  
 Fibers provide plant structure and are thus found in plant-derived vegetables, 
fruits, whole grains and legumes 
35
. A low-FODMAP diet restricts these food groups, 
suggesting fiber intake might be of concern. In our study however fiber intake did not 
change in either intervention. Total, soluble and insoluble fiber intake were considerably 
lower than the recommendations
36
, indicating attention should be paid to ensuring 
assuring adequate fiber in FODMAP modified diets in this population 
12
. 
 FODMAPs are low glycemic index nutrients 
37,38
 producing a lower glycemic 
response compared to other CHO 
21
. Low glycemic index foods may provide benefits in 
the treatment and prevention of metabolic syndrome, diabetes and CVD 
39-42
, due to their 
ability to maintain better regulation on blood glucose, decreases oxidative stress and 
lowering inflammation 
42
. No other study has considered how implementing a low-
FODMAP diet effects overall glycemic load or glycemic index. In our study, glycemic 
load (glucose reference) significantly decreased on the low-FODMAP diet, however, 
glycemic index (glucose reference) did not change (62.33±5.27 to 60.98±7.41, t=.597, 
p=.56). This change may very well be due to the decrease in overall CHO intake. Future 
studies should consider how FODMAP intake affects blood glucose regulation. 
4.5 The effect of overall FODMAP intake for the low-FODMAP diet 
 The low-FODMAP intervention was successful at reducing overall FODMAP 
intake and lactose intake; although it is important to keep in mind that oligosaccharides 
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were not calculated (see section 4.5, strengths and limitations). Overall FODMAP intake 
was almost cut in half on the low-FODMAP diet and 81% of subjects decreased 
FODMAP intake.  
 The low-FODMAP diet strategy does not recommend a FODMAP elimination 
diet for long term use and stresses the importance of reducing any unnecessary 
restrictions that may compromise nutritional status 
1,12
; The use of a strict low-FODMAP 
diet is warranted for 6-8 weeks 
1
 and subsequently discontinued if symptoms are not 
controlled 
4,43
. The cutoff point used to define low-FODMAP is based on the individual’s 
tolerance and typical eating pattern 
1, therefore to the researcher’s knowledge there is no 
formal definition of “low-FODMAP”. A previous study where all foods were provided 
defined low-FODMAP intake as <9 g/day
5
, which is lower than the 19.29 g consumed 
during our intervention. However comparisons to a standardized definition for low- or 
high-FODMAP cannot be made. 
  The low-FODMAP diet reduced lactose intake to under 3 grams and there was 
a nonsignificant trend towards calcium reduction. The “dairy” HEI-component, and 
vitamin D intake did not significantly decrease. The scores also rated poorly compared to 
desirable standards. The dairy score was lower than the average score for U.S. adults ages 
20-30 (5.6±0.2) despite the total HEI score greatly exceeding the population average 
(45.4±1.1) 
33
. Calcium intake at baseline exceeded the RDA of 1,000 mg/d 
44
  but 
dropped below the EAR of 800 mg/d 
45
 during the low-FODMAP diet. Vitamin D intake 
did not meet the EAR 
45
 at any point of the study. Calcium and vitamin D status in any 
nutrition intervention that greatly restricts lactose and/or dairy products should be 
considered 
22
. 
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4.6 Strengths and Limitations 
 There were several limitations. FOS and GOS were not included because they 
are not analyzed by NDS-R. Future studies could use Barrett and Gibson’s food 
frequency questionnaire
46
. A second limitation was that only a single 24 hour food recall 
was used per intervention period which provides an unstable estimate of usual intake
26,47
. 
A third limitation was that the high-FODMAP intervention was not effective at reducing 
FODMAP intake. Other limitations to this study include a small sample size, a short 
duration and reduced generalizability due to the homogeneity of college-aged subjects. 
Strengths of the study included the use of the HEI-2010, a well controlled, randomized 
single-blinded crossover experimental design, and use of healthy adults.    
 
5. CONCLUSION  
 Dietary instruction for implementing a low-FODMAP diet may be effective in 
helping young healthy individuals reduce FODMAP intake without compromising 
overall dietary quality. Although calcium intake was low, this study found that the low-
FODMAP diet was associated with a reduction in overall energy and carbohydrate intake 
as well as glycemic load. Long term studies are needed to confirm these results. Future 
research is also needed to assess the effects of increasing FODMAP intake in young 
adults. 
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Table 1: Demographics, n=16 
Variable     
Female, n (%) 
Male, n (%)  
10 (62.5) 
6 (37.5%) 
Age (yr), M±SD 
 
20.47±1.77 
Body Weight (kg), M±SD 
 
63.85±11.65 
Body Mass Index (kg/m
2
), M±SD 
 
22.21±2.45 
Waist Circumference (cm), M±SD 78.98±7.57 
Body Fat Percent (%)*, M±SD 18.80±10.37 
 
*body fat percent obtained via BOD POD Body Composition 
   System (Life Measurement Instruments, Concord, Calif., USA) 
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Figure 1: Comparison of 
FODMAP intake for low- 
vs. high-FODMAP diets.  
  
 
 
   Table 2: Diet quality as measured by the Healthy Eating Indix-2010 
  Low-FODMAP diet High-FODMAP diet ANOVA
a
 
HEI Component Baseline Day 3 Δ Baseline Day 3 Δ F (1,15) η
2
 
Total Fruit Score 1.93±1.99 2.83±2.19 0.9 2.35±2.21 2.29±1.69 -0.06 1.19 - 
Whole Fruit Score 2.46±2.41 3.01±2.30 0.55 2.52±2.19 2.37±2.04 -0.15 1.23 - 
Total Vegetable Score 3.38±2.02 3.62±1.94 0.24 4.32±1.19 3.22±1.88 -1.1 2.38 - 
Greens & Beans 0.71±1.91 2.39±2.51 1.68 2.18±2.24 1.89±2.28 -0.29 4.39 - 
Whole Grain Score 3.59±3.89 4.28±4.74 0.68 4.36±4.24 4.24±3.96 -0.11 0.28 - 
Diary Score 6.73±3.34 4.64±3.73 -2.09 7.17±3.07 6.80±3.63 -0.37 2.64 - 
Total Protein Score 2.99±1.75 4.40±1.30 1.41* 3.55±1.89 3.94±1.38 0.38 4.20 - 
Seafood & Plant Score 1.53±2.03 2.18±2.56 0.65 2.50±2.58 1.22±2.02 -1.28 1.75 - 
Fatty Acid Score 4.39±3.97 6.78±3.79 2.39 4.10±3.86 3.01±2.75 -1.09 3.53 - 
Refined Grain Score 5.28±4.28 7.69±3.69 2.4 6.41±4.06 5.03±3.82 -1.38 4.32 - 
Sodium Score 5.77±3.72 4.96±4.49 -0.81 6.13±3.50 2.99±3.35 -3.14** 1.78 - 
Empty Calorie Score 14.83±5.23 16.31±5.74 1.48 15.25±4.37 15.04±5.37 -0.21 0.97 - 
HEI-2010
b
 53.60±17.16 63.09±17.23 9.49* 60.83±12.76 52.04±11.27 -8.79* 10.452** 0.43 
*= p<.01, **=p<.001 
   
  A 2 (Order) X 2 (Treatment) X 2 (time) mixed factorial ANOVA with post hoc ttest was used for total HEI-2010  
and a 2 (treatment) X 2 (Time) repeated measured ANOVA with post hoc ttest was used for individual components 
a
= Time*treatment interaction F statistic reported 
   
  b
= A measure of dietary quality reflecting federal guidelines. Scores range from 0-100 with higher scores  
reflecting better diet quality.  The value is expressed as a per 1,000 kcal standard.  
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Table 3: Intake of selected nutrients in Low- vs. High-FODMAP diets  
    Low-FODMAP diet High-FODMAP diet ANOVAa 
Item Pre-Intervention Day 3 Δ Pre-Intervention Day 3 Δ F(1,14) η
2
 
Calories (kcals) 2255.83±1325.14 1510.11±794.96 -745.71* 1993.24±962.44 2251.92±864.46 258.68 8.62* 0.38 
Total:   
 
    
 
      
Fat (g) 83.76±65.77 55.24±33.28 -28.52 70.11±42.01 78.54±34.77 8.43 3.68 - 
Protein (g) 75.69±53.08 74.12±56.78 -1.57 74.92±34.14 91.53±36.51 16.61 1.30 - 
Carbohydrate (g) 291.72±186.21 182.86±116.27 -108.85* 277.60±144.01 288.01±131.68 10.41 6.28* 0.30 
Starch(g) 126.09±86.00 72.22±59.00 -53.87* 107.51±61.14 130.80±79.10 23.29 5.78* 0.28 
% Calories from:   
 
    
 
      
Fat  30.76±10.88 32.92±13.26 2.16 29.59±7.23 30.79±8.56 1.2 0.06 - 
Protein 13.45±5.15 19.21±9.02 5.76** 15.79±5.24 17.41±6.09 1.62 2.74 - 
Carbohydrate 51.97±13.32 46.96±16.66 -5.01 54.28±8.02 49.47±8.78 -4.81 0.15 - 
Sugars & Fibers   
 
    
 
      
Total Fiber (g) 21.22±14.15 16.13±8.27 -5.09 24.37±15.74 19.46±9.00 -4.91 0.00 - 
Soluble (g) 6.83±4.66 4.47±3.08 -2.36 7.01±4.29 6.42±3.60 -0.58 0.79 - 
Insoluble (g) 14.17±9.82 11.59±5.75 -2.58 17.26±12.35 12.89±5.90 -4.37 0.17 - 
Glucose (g) 21.87±14.73 18.52±16.07 -3.36 19.22±10.95 21.07±13.24 1.85 0.70 - 
Fructose (g) 20.52±15.03 16.10±15.03 -4.42 19.05±9.64 20.96±10.80 1.90 0.99 - 
Lactose (g) 14.35±14.08 2.89±5.79 -11.46** 15.96±16.40 11.29±12.11 -4.68 5.21* 0.26 
Sucrose (g) 64.13±73.51 38.59±32.68 -25.54 69.04±65.49 60.64±70.53 -8.40 0.62 - 
Total Sugars (g) 124.14±101.37 76.99±53.22 -47.15 126.96±83.41 118.47±80.88 -8.49 2.22 - 
Added Sugar (g) by total sugar 74.49±80.17 44.41±53.58 -30.09 77.07±80.23 75.03±73.62 -2.03 1.74 - 
Vitamins & Minerals:   
 
    
 
      
Vitamin D (mcg) 5.57±6.93 3.89±5.29 -1.68 4.75±3.54 3.86±2.55 -0.89 0.23 - 
Calcium (mg) 1085.97±794.13 689.12±451.61 -396.85 996.46±475.41 912.64±316.42 -83.83 4.65* 0.24 
Phosphorus (mg) 1278.96±803.39 998.83±578.54 -280.13 1314.86±583.87 1270.30±413.24 -44.56 1.51 - 
Sodium (mg) 3210±1760 2540±1810 -670 2730±1100 4260±1910 1530** 9.98** 0.40 
Potassium (mg) 2770.93±1429.83 2182.15±1171.89 -588.78 2549.06±752.78 2280.55±758.72 -268.52 0.51 - 
Glycemic load 170.46±117.52 105.15±77.33 -65.31* 151.88±84.39 162.29±84.52 11 6.77* 0.31 
*p<.05, **p<=.01 
      
  a=  Time x treatment interaction F statistic reported 
    
  A 2 (Order) X 2 (Treatment) X 2 (time) mixed ANOVA used for total calories intake and a 2 x 2 repeated measures ANOVA with post hoc ttests were used for all components 
2
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APPENDICES 
 
Appendix A: Review of Literature 
 
1. Irritable Bowel Syndrome 
 Irritable Bowel Syndrome (IBS) is the most commonly diagnosed 
Gastrointestinal (GI) condition in the United States 
48
. In 2012, it was estimated that 10% 
of Americans meet the diagnosable criteria for IBS, translating to 30 million people 
48
. It 
is considered a functional disorder with no known identifiable underlying 
pathophysiology 
49
 with diagnosis based on exclusion of other conditions rather than a 
biological marker and may involve lengthy, and intrusive procedures such as 
sigmoidoscopies and barium enemas 
50
.  Historically, medical management has focused 
on individualized symptomatic treatment
48
. IBS is an umbrella term that incorporates a 
spectrum of chronic or recurrent symptoms including abdominal pain, bloating, 
distension, excessive wind and altered bowel habits when anatomical abnormalities and 
inflammation have been excluded 
12
. Symptoms are experienced to varying degrees, often 
with a single symptom manifesting predominately. Some symptoms can be perceived to a 
lesser degree by the healthy population, indicating that some treatment strategies may be 
beneficial to the general population
5
. 
 
1.2 IBS’S Burden on Healthcare and Affect on People’s HRQoL 
 It is well documented that IBS is associated with a decrease in people’s sense of 
well-being, or Health Related Quality of Life (HRQoL) in relation to the general 
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population 
51-54
. In 2009, Spiegel et al. 
51
 found that patients with IBS visit the doctor 
more frequently, use more diagnostic tests, consume more medications, miss more 
workdays, have lower work productivity, are hospitalized more frequently, and consume 
more overall direct costs than those without IBS. Recent studies have compared HRQoL 
of IBS patients to patients with other gastrointestinal conditions. A 2000 study looked at 
877 ambulatory adults from 1994-1998 and compared HRQoL of IBS patients with the 
general population and with patients with GERD, Diabetes Mellitus (DM), depression 
and End Stage Renal Disease (ESRD) on dialysis 
55
. The study found that patients with 
IBS had significantly worse reported HRQoL than the general population and patients 
with GERD. Additionally, patients with IBS scored significantly lower on selected 
aspects of HRQoL than patients with DM and ESRD. The study concluded that IBS 
patients experience significant impairments in HRQoL and these impairments are most 
pronounced in energy/fatigue, role limitation caused by physical health problems, bodily 
pain and general health perception 
53
.  
 IBS’s impact on the healthcare system has also been heavily researched. The 
overall associated cost is 1.6 billion in direct and 19.2 billion in indirect annual costs 
56
. 
The mean annual direct health care cost per patient is $5,049 and the annual out-of-
pocket expenses (for example non-prescription medication and alternative treatment like 
special diets and therapy per patient) is $406 
57
. The individual cost has been found to 
increase based on disease severity and recent exacerbation of bowel symptoms 
57
. 
Regarding burden for healthcare practitioners, IBS accounts for 12% of the patients seen 
in the primary care practice and is the largest diagnostic group seen in GI practice 
58
 with 
inpatient care accounting for 17.5% of total costs 
57
.    
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1.3 Treatment of IBS Focusing on the Role of Diet 
 Current treatments for IBS include pharmaceuticals such as antispasmodics and 
stool softeners 
12
, psychological therapy, fiber, probiotics and lifestyle and diet 
modification 
8
. The American Gastrointestinal Association (AGA) suggests that treatment 
of IBS should be based in part on the correlation of IBS symptoms with food intake and 
defecation 
58. Food’s role in symptom management is further reinforced by an Academy 
of Nutrition and Dietetics (AND) study that concluded symptoms in one quarter of IBS 
patients may be caused or exacerbated by one or more dietary components 
59
 as well as 
multiple studies finding people with IBS believe food plays a significant role in 
exacerbation of their symptoms 
60-64
.  
 Multiple foods or food components have been examined regarding their role in 
IBS symptom exacerbation. Dietary fat, caffeine and alcohol have been sought after as 
potential triggers with physiological mechanisms suggesting that these may play a role, 
but inconsistencies in symptom improvement have been seen when these items are 
restricted 
12
. In 2009, the AND 
59
 released a position paper comparing the current 
practical treatment strategies for IBS. The position paper states that the traditional dietary 
strategy of increased fiber is only marginally beneficial. In addition, a subgroup of fiber, 
insoluble fiber, may actually worsen symptoms, making the traditional dietary advice 
confusing and potentially counterproductive. Indeed, randomized controlled clinical trials 
have shown conflicting results 
65,66
. The AND also examined new treatment strategies, 
specifically supplemental prebiotics and probiotics and dietary fermentable oligo-, di- 
monosaccharides and polyols (FODMAPs) restriction. FODMAP is a term used to 
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identify a collection of poorly digested, highly osmotic and rapidly fermented short chain 
carbohydrates (CHO). At the time of that paper, the AND stated that prebiotics have not 
been adequately tested, the usefulness of probiotics was not yet established and the 
restriction of dietary FODMAPs may be beneficial in reducing IBS symptoms, but 
confirmatory studies were needed
59
. 
 
2. FODMAP: Definition & General Properties 
 In 2005 the term FODMAP was coined to identify a collection of poorly 
digested, highly osmotic and rapidly fermented short chain carbohydrates (CHO). 
FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and 
polyols. They are widespread in the diet 
1
 and include the oligosaccharides, 
fructooliogosaccharides (fructans or FOS), found in wheat, rye, onions and garlic, and 
galactooligosaccharides (GOS) found in legumes and some nuts; the disaccharide lactose 
found in milk products; the monosaccharide fructose in apples, pears, watermelons, 
mango and asparagus and the sugar polyols used as artificial sweeteners and naturally 
occurring as sorbitol in stone fruits and mannitol in mushrooms and cauliflower 
12
. Both 
dietary fibers and resistant starches are also poorly digested in the small intestine and 
reach the colon, however they are not fermented as fast and are less osmotically active 
making them less likely to induce gastrointestinal symptoms 
12
 and thus not considered as 
part of this IBS-focused dietary strategy. Indeed, studies have shown the benefits of low-
FODMAP diets in alleviating IBS symptoms even when adequate resistant starches and 
fibers are included 
5,7
. 
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 FODMAPs have three common functional properties. They are 1) poorly 
absorbed in the proximal small intestine, allowing substrate to reach the distal small 
intestine and proximal colon 2) small and osmotically-active, which increases the 
liquidity of luminal content due to osmosis and 3) rapidly fermented by gut microbiota, 
increasing the amount of gas present in the colon. These three characteristics combined to 
increase luminal distension 
1
, the basis for the genesis of many functional gut syndrome
1
. 
A low-FODMAP diet is now considered an effective strategy for managing symptoms of 
IBS in Australia, with interest expanding across the world 
12
. Studies have also shown 
that a low-FODMAP diet can relieve gastrointestinal symptoms in up to 70% of patients 
with Crohn’s disease and Ulcerative Colitis10, two conditions that historically exhibit 
functional gastrointestinal symptoms similar to IBS. Additionally, FODMAPs in enternal 
nutrition (EN) feeding formulas have been suggested as a contributing factor to high 
frequency of diarrhea in patients receiving EN support 
67
.The predominant symptoms of 
IBS are diarrhea, bloating, abdominal pain and flatus 
48
.  It is important to note that low-
FODMAP diets do not treat IBS; rather they provide a therapeutic strategy for managing 
symptoms. The osmotic nature of FODMAPs contributes to diarrhea and the fermentation 
gaseous by-products contribute to abdominal pain and flatus 
12
. The improvement to 
constipation-predominate IBS seen by the FODMAP approach needs further exploration 
12
. Lastly, the threshold of visceral pain, or visceral sensitivity may help determine the 
severity of symptoms, in particular abdominal pain 
3
.  
  
2.2 FODMAP Studies: Studies Confirming the Success of Low-FODMAP in Treating 
Gastrointestinal Symptoms 
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 Since the AND’s 2009 position paper, multiple studies have concluded that 
high-FODMAP diets induce gastrointestinal symptoms 
5,6
 and that a low FODMAP diet 
relieves gastrointestinal symptoms associated with functional gastrointestinal disorders 
7-
10
. Overall symptom improvement has been seen in up to 86% of IBS patients
7
 and, 
although the majority of FODMAP studies focus in on IBS patients, limited studies on 
patients with Inflammatory Bowel Disease (IBD) displaying IBS-like symptoms show up 
to 70% symptom improvement 
8
. The first and only prospective study confirming that 
low-FODMAP diet improve IBS symptoms was conducted in 2013 
8
. The study 
examined 90 patients with a mean follow up of 15.7 months. With the exception of 
‘burping’ (p=.275), ‘feeling full even long after stopping eating’ (p=.051) and ‘the 
passage of mucus’(p=.890), (all of which are symptoms not traditionally associated with 
IBS), there was a significant improvement in all of the 20 questions pertaining to bowel 
habits. This included significant improvements in abdominal pain, bloating, flatulence 
and diarrhea (p<.0001 for all) 
8
, the predominant symptoms of IBS 
48
.  
 Shepherd et al. 
11
 conducted the first and only randomized placebo-controlled 
study showing evidence that restriction of FODMAPs causes symptomatic improvement 
in IBS patients. The study was a 25 subject, double-blinded, randomized, quadruple arm 
placebo-controlled rechallenge trial. The aim of the study was to determine if 
improvement in symptoms in IBS patient following fructose restriction was due to 
fructose specifically or FODMAPs in general. The 25 patients were provided all foods for 
the study duration. The subjects first completed an initial 4 week period where foods that 
contained FODMAP were restricted, followed by a 26 day period where subjects 
consumed specially formulated test drinks containing fructose, fructans, a combination of 
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fructose and fructans or glucose (the control) in different dosages. Symptoms were 
measured using daily diaries and questionnaires. For each arm, participants started with 
the low dose (50mL/week) for the first 3 days, followed by the medium dose (100 
mL/day) for 3 days and finally the high dose (170 ml/d) for the remaining 2 weeks of 
each arm. Dose stages were increased as tolerated with no significant difference in 
patients’ ability to reach the high dose in any of the drinks. Each 500 ml bottle contained 
19 g fructans, 50 g fructose, a combination of the fructose and fructans representing a 
FODMAP containing drink, or 20 g glucose representing the control. The test drinks 
were initially tested on seven healthy adults without IBS. None of the healthy adults 
reported their symptoms were not adequately controlled; However four healthy subjects 
reported mild symptoms, three reported bloating (VAS scores of 27,35,43 mm) and four 
reported increased wind (VAS scores 27,28,33, and 44 mm). Following the initial arm, 
subjects could not begin the subsequent arm of the study until baseline symptoms were 
obtained for at least seven days. The overall adherence was >95%. The median wash out 
period was 14 days. The study resulted in 70% of patients receiving fructose, 77% 
receiving fructans and 79% receiving a high FODMAP drink reported uncontrolled 
symptoms compared to only 14% of subjects receiving glucose (p≤.002). Every IBS 
symptom evaluated was significantly greater with ingestion of the high FODMAP drink 
than the control. In addition, intensity of overall symptoms increased as the doses of 
fructose, fructans and fructose-fructan mix increased (p<.01 for all dose comparison) but 
the severity of overall symptoms did not change for increasing doses of glucose (p>.2). 
 
2.3 Comparing low-FOMDAP diets to standard dietary advice 
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 In 2011 Staudacher et al.
7
 compared symptom responses in IBS patients after 
advice to follow a diet low in FODMAPs verses following the standard dietary advice by 
on the UK National Institute for Health and Clinical Excellence (NICE) guidelines. The 
study took place in the United Kingdom and all dietary advice was given by experienced 
dietitians. The NICE guidelines consist of general dietary advice including regular meal 
patterns (adjusting fiber intake and reducing alcohol and caffeine) as well as symptom 
specific guidelines 
7
. The study looked at 82 consecutive IBS patients (standard n=39, 
low-FODMAP n=43) who attended a follow-up dietetic outpatient appointment after 
following dietary advice for management of IBS for at least 6 months. The validated IBS 
Global Improvement Scale was used to compare symptom changes between the two 
groups. The study found that the low-FODMAP diet produced greater satisfaction in 
symptom responses (76%) compared to the standard advice (54% p<.038) and better 
overall symptom responses (86%) compared to the standard group (49% p<.001). 
Improved symptoms included reduced bloating, abdominal pain and flatulence.  
 
2.4 FODMAP malabsorption 
 Although all FODMAPs are poorly absorbed, the anatomical reasoning 
underlying the incomplete or complete lack of absorption differs among FODMAPs. 
Fructose is a hexose sugar being increasingly consumed in its monosaccharide form as an 
added sweetener and in its more natural forms such as fruit juice 
68
.There is no clearly 
established fructose malabsorption mechanism 
68
 and most of the understanding of 
fructose transport has been based on animal studies 
69
. In the conventional model of 
fructose transport, fructose is transported across the apical membrane of intestinal 
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epithelial cells by the facilitative transporter GLUT5 
68
, a facilitative transporter specific 
to fructose. Transport of fructose across the basolateral membrane of gastrointestinal 
epithelial cells takes place by means of the facilitative transorter GLUT2, which has the 
ability to transport both hexose monosacchrides, fructose and glucose 
68
. A study 
conducted in GLUT5 knockout mice identified GLUT5 as the primary protein 
responsible for fructose absorption and malabsorption 
70
. These GLUT5 knockout mice 
displayed decreased fructose absorption by 75% and decreased serum fructose by 90% 
when compared to wild-type mice. Furthurmore, GLUT5 knockout mice fed a high 
fructose diet experienced more distended colons and significantly more fecal contents 
including fluid and gas compared to mice on a normal or high glucose diet. Fructose 
absorption in humans appears to be limited at high concentrations of fructose consistent 
with the absorption capacity of a facilitative transport system, and appears to occur as a 
result of a reduced absorption threshold 
68
. This means that among both healthy and 
symptomatic people, there is a range of fructose absorptive capacity that is balanced 
against dietary fructose consumption 
68
. 
 Lactose malabsorption is a common condition characterized by a deficiency of 
lactase, an intestinal cell produced enzyme occurring in the brush border membrane of 
the intestinal mucosa that hydrolyzes lactose to its components, galactose and glucose 
71
. 
Secodary hypolactasia can be the result of any condition that damages the small intestinal 
mucosa brush border or significantly increases the gastrointestinal transit time 
71
. Both of 
these conditions result in malabsorbed lactose reaching the colon. Only when the 
malabsorbed lactose is associated with clinical manifestation of bloating, flatulence, 
abdominal pain and diarrhea is it referred to as “lactose intolerance”71. 
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 FOS or Fructans are oligo- and polysaccharides of fructose with a glucose 
terminal end 
16,72. They are classified according to their bonds as inulins (β1-2 bonds) or 
levans (β2-6 bonds) with most dietary sources coming from inulins 16. When an inulin 
has <10 degrees of polymerization (DP) it is referred to as a fructo-oligosaccharide, 
whereas >10 DP is referred to as an inulin 
16. The β-bonds that hold fructose molecules 
together are unable to be hydrolyzed by human digestive enzymes, thus theoretically FOS 
travel unabsorbed in all humans, resulting in more than 90% of fructans reaching the 
colon 
16
. That being said, FOS absorption in the human gastrointestinal tracts has not 
been assessed, studies come exclusively from rat models 
73
.    
 GOS are nondigestible CHO usually composed of 2-10 molecules of galactose 
and 1 molecule of glucose 
74
. The two most common dietary sources are raffinose, 
comprised of one fructose, one glucose and one galatose molecule and stachyose, which 
is a raffinose with one an additional galactose 
16. Humans lack α-galactosidase, the 
enzyme that hydrolyses the galactosidic linkages of stachyose and raffinose to their 
simple sugar constituents, resulting in minimal absorption in humans 
16
. 
 Polyols are sugar alcohols that include sorbitol, lycasin, malitol and mannitol, 
75,76
. Sorbitol and mannitol are six-carbon polyols isomers that are only partly absorbed 
via passive diffusion across the small intestine epithelium 
76
, with a total of 80% ingested 
reaching the colon 
16
.  
 
2.5  Intestinal gas production and the hydrogen breath test 
 Once CHO are malabsorbed in the small intestine they become substrate for 
bacteria fermentation, which in turn releases gaseous byproduct into the lumen. More 
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than 99% of intestinal gas is hydrogen (H2), oxygen (O2), methane (CH4), carbon dioxide 
(CO2) and nitrogen (N2) while less than 1% is composed of various odoriferous gases 
77
. 
CO2, H2 and CH4 represent the predominant, intraluminal gases 
77
. H2 and CH4 are 
generated solely by bacterial metabolic processes, demonstrated by studies conducted 
with both germ free rats and newborns, which show that these gases are not produced 
during the first 12 hours of life 
78,79
. Colonic gases will be used by bacteria, excreted in 
stool or absorbed into the blood stream 
80
. Absorbed H2 is almost completely cleared in a 
single passage through the lungs 
80
, thus the measurement of breath H2 concentration may 
be considered an expression of intestinal H2 production 
81
. The human colon contains 
around 10^15 bacteria 
82
, predominantly anaerobes that produce large quantities of 
hydrogen gas 
83
. Anaerobic bacteria prefer to metabolize sugar molecules, which get 
broken down into short-chain fatty acids (SCFA), CO2 and H2 
83
. Like H2, SCFA generate 
an osmotic gradient, attracting water into the colon, which can lead to diarrhea 
83
. There 
are two main pathways for colonic H2 disposal, including conversion to methane by 
methanogens and hydrogen sulfide production from reduction of sulfate by sulfate 
reducing bacteria 
77
. Of the general population, 30% have microbia containing enough 
methanogens to allow for consumption of large quantities of hydrogen, while producing 
small amounts of H2 
84
 made possible since four moles of H2 can be reduced to a single 
mole of CH4
77
.   
 The hydrogen-breath test is a simple, non-invasive tool currently used in 
gastroenterology to diagnose certain clinical conditions, thus avoiding more invasive test 
85
. Additionally, it represents the most effective test for CHO malabsorption 
86
 and is used 
extensively in both individual and collective FODMAP studies. It relies on the fact that 
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humans do not normally produce H2 and thus its presence indicates breakdown of CHO 
in the intestines, primarily the colon, by anaerobic bacteria 
87
. FODMAPs have been 
called fast food for bacteria 
16
 and breath hydrogen testing studies have shown that CHO 
molecules with DP<10, such as FODMAPs, are broken down twice as fast those with 
DP>10 
88
. In 2000, a breath hydrogen detection machine entitled the Quintron Microlyzer 
Breath H2 Analyzer was validated for diagnosis of CHO malabsorption 
87
. 
 
2.6 FODMAP malabsorption in healthy adults  
 The predominant way that diet alters luminal distention is via intraluminal gas 
production 
5
. Even in healthy individuals, FODMAPs are malabsorbed 
12
,  shown using 
breath hydrogen testing to compare the prevalence of CHO malabsorption between 
functional GI disorder (FGID) patients and healthy subjects. Barrett et al. 
17
 found that 
34% of healthy people (n=71) malabsorb fructose compared with 45% of those with 
FGID (n=201) when given 35 g of fructose prior to breath hydrogen testing 
(malabsorption was defined as >10 ppm). In that same study 
17
 it was demonstrated that 
lactose malabsorption occurred in 16% of healthy adults compared to 23% with FGID 
after ingesting 50 g of lactose. Two years later, Yao et al 
18
 conducted a randomized, 
double-blinded, placebo-controlled cross over study comparing polyol malabsorption 
between IBS patients (n=20) and healthy adults (n=21) after ingestion of 10 g of polyols. 
The study found that IBS patients had less malabsorption than healthy adults (sorbitol 
1629 ± 210 ppm. 4 hour vs. control 2766 ±591; mannitol 601± 228 vs 2062 ± 468, p= 
0.02; t-test) and the prevalence of malabsorption among healthy adults was 60%. As far 
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as the oligosaccharide FODMAPs, as stated previously, malabsorption occurs in 
everyone 
19,20
.  
 Intestinal gas produced after ingestion of total FODMAP in both healthy 
individuals and individuals with IBS has also been considered. In 2010, Ong et al.
5
 
examined both healthy individuals (n=15) and patients with IBS (n=15) and compared 
high-FODMAP diets (50g/day) to low-FODMAP diets (9 g/day) during a two day 
intervention. The design was a single-blinded crossover intervention where all food was 
provided. Breath hydrogen samples were collected hourly over 14h on day two of each 
diet. The study found higher levels of breath hydrogen produced over the day with the 
high-FODMAP diet for healthy subjects (181± 77 ppm vs. 62±23 ppm; mean p<.0001) 
and patients with IBS (242±79 vs. 62±23; p<.0001) 
5
.  
 
2.7 Importance of visceral sensitivity in symptom production 
 With CHO malabsorption present in both healthy population and FGID patients, 
and fermentation patterns similar in both populations, a low threshold for visceral pain 
appears to be the key mediator for gastrointestional symptoms manifestation, particularly 
abdominal pain
3
. This was demonstrated by Richie et al. 
3
 who studied the effect of 
inflating a balloon into the distal colon and compared pain responses between IBS 
patients (n=67) and healthy adults (n=16). The study found that inflation to 60 mL caused 
pain in 6% of the control at a mean diameter of 3.8 cm and in 55% of patients with IBS at 
a mean diameter of 3.4, despite that gut wall tension at that volume appeared to be 
normal in both groups and gut wall diameter could be further increased. Additionally, in 
6% of the controls and 52% of patients with IBS, pain occurred at balloon diameters that 
  
41 
 
could still be increased by 10% or more with further inflation, pointing to a low threshold 
for visceral pain in patients with IBS compared to healthy adults 
3
. 
 
2.8 Poorly digestible and Osmotic effect of FODMAP 
 The proposition that dietary FODMAPs increase the liquidity of luminal content 
due to osmotic properties was explored in a ‘proof-of-concept study’ in 2007 9 and 
further explored in a similar study in 2010
6
. The Australian study examined the change in 
frequency and consistency of effluent of patients without a colon when reducing 
consumption of dietary FODMAPs. The use of colonoscopy patients controlled for the 
reabsorptive capacities of the large bowel to help better understand how much liquid 
diffuses into the intraluminal space in the small intestine. In the small, 15 subject study 
that incorporated both retrospective and prospective data, patients who recently received 
a colectomy and ileal pouch formation (n=13) or a ileorectal anastomosis (n=2) had the 
frequency and consistency of effluent output per day measured prior to and during a low-
FODMAP intervention. All participants had breath hydrogen testing done prior to 
participating in the study. Regarding breath hydrogen testing, 50% of the participants did 
not produce hydrogen. This is understandable given the absence of colonic fermentation 
in patients without a colon. In the retrospective arm of the study, five of the seven 
patients had significant improvement in stool frequency (8-4 stools; p=0.02) and 
consistency as shown by patient self reporting 
9
. In addition, patients uniformly reported 
that reintroduction of prohibited foods worsened symptoms 
9
.  In the prospective arm of 
the study, (n=5), no significant change in stool frequency (median 6 to 5 per day; p=ns) 
occurred. The lack of significance was attributed to acute or chronic pouchitis 
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experienced by three subjects 
9
. However the reasoning for the lack of response in 
patients with inflammation was unclear 
9
. 
 Similarly, a 2010, randomized, single-blinded cross over study where subjects 
without a colon were given high-FODMAP diets found that effluent liquid output closely 
related to FODMAP output, clearly demonstrating FODMAPs osmotic properties 
6
. This 
was found by measuring FODMAP output in the stool of subjects. The study consisted of 
twelve illeostomy patients who for four days consumed diets differing only in FODMAP 
content. Effluent was collected for 14 hours during the final day of each intervention. 
Effluent recovered from the high-FODMAP diet contained 32% (range 6-73) of ingested 
sorbitol and fructans 
6
. Furthermore, stool weight increased by 22% (95% CI, 5-39), 
water content by 20% (2-38%) and dry weight by 24% (4-43%) 
6
.   
 
3. Studies Examining Adherence to low-FODMAP diets 
 Dietary adherence is crucial to the success of a low-FODMAP diet, however 
most people do not find the diet easy to incorporate into their life 
8,10
. That being said, 
studies have shown high adherence rates among functional gastrointestinal disorder 
(FGID) subjects both when all foods are provided in the form of test drinks (>95%) 
11
 
and when asked to follow dietary advice (75.6%)
8
. Adherence among the healthy 
population who do not experience comparable symptoms has yet to be studied.   
 Croagh et al. 
9
 considered change in FODMAP intake, which was used to define 
adherence in a study examining administration of a low-FODMAP diet. The study was a 
small, combination retrospective/prospective study, with a total of 15 subjects. In the 
prospective group, adherence was measured on five subjects using seven-day food 
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records reflecting the intake on the final week of the six week intervention. Adherence 
was based on total number of “problematic serves” per day, defined as any food that 
contained >.5 g of free fructose or fructans, >4 g lactose or any sorbitol, which was based 
on guidelines from a previous study
25
. Each of the five participants reduced the number 
of problematic serves per day by at least 6.5 serves (P1=8-1.5, P2=12-2, P3=11-0, P4=9-
0, P5=12-5) by the end of the intervention. According to Croagh et al.
9
, those with a high 
baseline intake of dietary FODMAPs and good adherence to the diet responded, while 
those with a low baseline intake and partial adherence did not 
9
.  
 In another study, de Roest et al.
8
 measured correlations between adherence and 
symptoms among IBS patients, finding a positive correlation between adherence to a 
low-FODMAP diet and symptom improvement. Follow up questionnaires were used to 
measure both adherence and symptoms at a mean follow up time of 15.7 months. All 
symptom improvement, including abdominal pain, bloating, flatulence and diarrhea was 
significantly associated with adherence (r>0.27, p<0.011). In this 90 subject study, 75.6% 
(n=68) of IBS patients adhered to the diet regimen. Breaking down adherence into 
subcategories, 45.6% (n=32) followed the diet as taught at all times except on some 
occasions; 12.2% (n=11) followed the diet at all times; 13.3% (n=12) patients followed 
the diet all the time except eating away from home; 14.4% (n=13) considered themselves 
adherent at least 50% of the time; 24.4% (n=22) followed the diet up to 3 months, but not 
anymore; 5.6% (n=5) followed the diet as taught immediately, but less than 50% of the 
time at the end of the follow-up questionnaire; 4.4% (=4) never followed the diet 
8
.  
 
3.2 Factors that may contribute to adherence 
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 Gearry et al. 
10
 conducted a pilot study that explored factors that may contribute 
to non-adherence to a low-FODMAP diet in patients with Inflammatory Bowel Disease 
(IBD) based on findings from a previous FODMAP study
11
. Dietary advice consisted of a 
single one-on-one or group counseling session with a dietitian as well as FODMAP 
literature and food lists. Adherence was measured using questionnaires via structured 
telephone interviews regarding FODMAPs consumption as well as specific questions 
concerning FODMAP-containing foods in order to validate the patient’s responses. 
According to Gearry et al.
10
 70% of IBD patients who suffered from FGID were adherent 
to advice to follow a low-FODMAP diet. Upon completion of the study, the 72 
participants were asked to rate their opinion of the diet on a scale of 0-10 (0=easy, 
10=impossible) and obtained median score. Low scores were obtained for the questions 
1] how easy was it to implement the diet (median response 3; SD 2.9, range 0-10, 
interquartile range 0-5), 2] and how easy was it to buy the appropriate foods (median 
responds 3; SD 2.9, range 0-10, interquartile range 1-4) and 3] how would you rank the 
overall taste of the diet (median responds 2; SD 2.2, range 0-10 interquartile range 1-4)
10
. 
In addition, 44/72 (61%) said that the foods were not available at their usual shops, the 
higher cost of the diet was thought to be problematic for 46/72 (64%) and the median 
estimated increase in the cost of food while on the diet was 10% (SD 19, range -10-
110%, interquartile range 1-25%). 
 The de Roest et al. 
8
 study (described above) examined similar factors 
contributing to non-adherence in a study consisting of 90 IBS patients. Using 
questionnaires, the study found that that fifty-one (60%) patients stated the diet was easy 
to follow, 56 (65.1%) could easily find suitable products and 37 (54.7%) were able to 
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incorporate the diet easily into their lives; the overall taste was liked by 47 (54.7%) 
patients, 21 (24.4%) of patients thought the diet was too expensive
8
. Last, regarding 
dietary advice, sixteen (44.6%) patients believed that simply being given a list of foods to 
avoid would have been as effective as seeing a dietitian while 37 (44.6%) of patients 
would have liked to have seen the dietitian for a further follow-up appointment 
8
.  
Additionally, patients were asked to rank order 5 variables reflecting how they 
contributed to efficacy/adherence to the diet. Written information (mean rank 1.73 
(±0.76)) and dietitian consultation (1.89 (±1.09)) were ranked highest while the support 
of family and friends (3.33 (±1.15)), low FODMAP cookbooks (3.89(±1.00) and online 
information (4.11 (±1.00)) were ranked as less important.  Factors contributing to non-
adherence have been investigated in both IBS and IBD populations, but not in healthy 
adults.  
 
4. Potential Limitations of a low-FODMAP diet 
 Several limitations of a low-FODMAP diet pertaining to dietary quality and 
health benefits have been suggested. Malabsorbed FODMAPs provide multiple benefits 
including a natural laxative effect due to their osmotic effects
6
, a prebiotic effect with 
beneficial fermentation by-products 
12
 and production of  a low glycemic response 
compared to other CHO 
21
. Some beneficial by-products of fermentation include short 
chain fatty acids (SCFA), which may protect against colon cancer as well as promote 
satiety 
89
, and synthesis of B vitamins and vitamin K 
90
.  
 
4.2 FODMAPs: Low-glycemic index nutrients 
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 FODMAPs are nutrients with lower glycemic indexes 
37,38
. Low glycemic index 
foods are proven beneficial in the treatment and prevention of metabolic syndrome, 
diabetes and CVD 
39-42
. Although the mechanisms underlying the effects of these foods 
are not completely understood it is hypothesized that low-GI diets maintain better 
regulation of blood glucose, which decreases oxidative stress and lowers inflammation 
42
. 
In addition to immediate response, consumption of low glycemic foods reduces glycemic 
response at subsequent meals up to 4 hours later 
21
.  
 Nilsson et al.
42
 conducted  a study examining the effect of evening consumption 
of indigestible and low glycemic-index foods (50 grams) on a subsequent breakfast. The 
study included healthy subjects exclusively and used breath hydrogen testing to reflect 
colonic fermentation. Testing was done prior to and after a subsequent standardized 
breakfast as well as three hours postprandial.  Results were healthy subjects improved 
glucose tolerance, lowered inflammatory markers and increased satiety (which 
contributes to weight control and obesity prevention) suggesting multiple benefits of 
including indigestible and low-GI foods. Upon further investigation, glucose response 
was inversely correlated with colonic fermentation (r=-0.25; p<0.05) and breath 
hydrogen was positively correlated to satiety (r=0.27; p<0.01). Nilsson et al. concluded 
that the effects could be attributed to mechanisms involving the prebiotic effect of poorly 
digested CHO.  
 
4.3 FODMAPs: Prebiotic Actions 
 Prebiotics are any nondigestible substances that encourage the growth and 
activity of favorable intestinal bacteria, known as probiotics, therefore improving the host 
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health 
91
 and include the FODMAPs FOS, GOS and inulins 
92
. Studies have shown that 
supplementing with FOS, GOS and inulin encourages growth of the beneficial bacteria 
bifidobacteria, at the expense of less desirable groups of bacteria 
93,94
. Beneficial 
probiotics also include the bacteria lactobacilli; However bifidobacteria are the usual 
target since these bacteria are more readily altered and more prevalent in the human colon 
95
.  Bifiobacteria also exhibit a preference for oligosaccharides 
95
. Prebiotics may 
promote satiety, weight loss and prevent obesity, lower some risk factors for 
cardiovascular disease, enhance the bioavailability and uptake of minerals including 
calcium, magnesium and possibly iron, exert protective effects that may prevent colon 
cancer, reduce inflammation and symptoms of inflammatory bowel disease and reduce 
the prevalence and duration of infectious and antibiotic-associated diarrhea
95
. Recent 
studies have shown that prebiotics can have positive effects on insulin and immune 
response and decrease total cholesterol and total glucose concentration after just six 
weeks of use 
94
 and increase the amount of bifidobacteria after just four weeks 
96
, 
however no longer term studies have been reported.  
 Not all dietary fibers are prebiotics, but all prebiotics such as oligosaccrides are 
dietary fibers 
97
. Benefits of consuming adequate fiber include weight management, 
lowering of blood cholesterol, colon cancer risk reduction, prevention and control of 
diabetes and enhancement of colonic health 
35
. Fiber provides the structure of plants and 
are thus found in plant-derived foods including vegetables, fruits, whole grains and 
legumes
35
. A low-FODMAP diet restricts these foods suggesting that dietary fiber intake 
might be reduced. No study has measured change in fiber intake in diets that vary in 
FODMAP content. 
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4.4 Dietary quality of Low-FODMAP diets 
 Only one retrospective study has calculated the diet of free-living subjects who 
received low-FODMAP dietary advice. Not one study has looked exclusively at healthy 
adults, changes in intake or looked at overall diet quality as compared to established 
guidelines. Ostgaard et al.
23
 examined the breakdown of IBS patients diets who received 
low-FODMAP dietary education (guided n=43) two years prior. The study compared 
those results to IBS patients who did not get FODMAP education (unguided n=36) and to 
a group of healthy individuals (control n=35). Food frequency questionnaires (FFQ) were 
used to assess dietary intake. Dietary advice consisted of two sessions with a trained 
nurse for one hour each. The FFQ found there was no statistical difference in the intake 
of calories, CHO, protein, fat or sugar between the guided, unguided and control and a 
significantly lower consumption of alcohol (beer and wine) in both the guided and 
unguided IBS patients when compared to the control. (Beer and wine: control;45.0±10.9 
and 34.2±.9 ml, guided; 21.0±6.5 and 16±2.9 ml, unguided; 13.9±5.9 and 14.5 ±4.3 ml 
respectively) 
23
. Fiber however was not assessed as significantly different among the 
three groups and overall dietary quality was not measured.      
 
5.  CHO malabsorption ‘s effect on mood 
 Multiple studies have been conducted linking specific CHO malabsorption to 
changes in mood or increases in undesirable mood states. Ledochowski et al. conducted a 
series of studies in otherwise healthy adults linking fructose malabsorption 
98
 and lactose 
malabsorption 
99
 to early signs of depression and mood disturbances, and fructose and 
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sorbitol reduced diets 
100
 to increases in mood among malabsorbers. Mood was defined 
by the participants’ score on the Beck’s Depression Inventory-Questionnaire (BDI) 101. 
  When examining the connection between malabsorption and mood scores, 
Ledochowski et al. considered plasma tryptophan 
98
.  This particular study enrolled fifty 
adults with gastrointestinal discomfort but without any clinical diagnosis. Subjects were 
tested for fructose malabsorption using breath hydrogen testing. Baseline testing was 
done followed by administration of 50 grams of fructose. Breath hydrogen testing was 
then repeated every 30 minutes for the next two hours. Fructose malabsorption was 
defined as an increase of more than 20 ppm over basal fasting value. Patients (n=35) 
(70%) were classified as fructose malabsorpers. Fructose malabsorbers and non-
malabsorbers then had their plasma trophophan measured and completed the BDI. A non-
significant trend to higher BDI scores was seen comparing fructose malabsorbers to non-
malabsorbers (9.47±7.35 vs. 7.07 ± 4.62, p=NS). However once divided based on gender, 
BDI was higher for female fructose malabsorbers (12.30±7.16) than female non-
malabsorbers (6.66 ±5.50, p=.002). No difference was seen in males. Mean plasma 
typtophan was significantly lower in fructose malabsorbers than non-malabsorbers 
(p=.02) and once again, divided by gender, lower tryptophan concentrations were only 
seen in females (fructose malabsorbers: 61.3±14.0μM, normal:74.7±16.5 μM, p=.03).  
Upon further statistical analysis, individuals with tryptophan concentrations lower than 
the median (=67.0μM) more often presented with a BDI score above the median (p=.036; 
Fisher exact test) and when analyses was restricted to fructose malabsorbers, a significant 
inverse relationship between tryptophan concentration and BDI scores were found both 
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overall (n=35; r=-0.348, p=.043) and when restricted to females (n=24; rs=-0.503, 
p=.014).  
5.2 Tryptophan levels and Mood 
 Although serotonin (5-HT) is often thought of as a neurotransmitter exclusive to 
the central nervous system (CNS) due to its well-defined role in expression of depression, 
arousal, pain and other characteristics commonly attributed to CNS functioning, the 
major source of bioavailability is located in the bowel 
102
. Low levels of brain 5-HT can 
contribute to decreases in mood 
103
 and are therefore the target of several antidepressants. 
The precursor of 5-HT is tryptophan, which is considered an essential amino acid, 
indicating it cannot be produced internally and must be obtained externally via the diet. 
Lowering tryptophan levels through dietary modifications is associated with a 
postprandial mood-lowering effect 
104
.  
  Ledochowski et al.
98
 demonstrated that malabsorption of an individual 
FODMAP has been associated with decreases in tryptophan levels. According to this 
study, high intestinal fructose concentrations, as is the case with fructose malabsoprtion, 
seem to interfere with L-tryptophan metabolism and thus reduce the bioavailability of 5-
HT. It was then hypothesized that this could be due in part to a combination of increased 
transit time and the phenomenon known as the Maillard reaction. The Maillard reaction, 
which is primarily associated with food science, is a heat-driven process where an amino 
acid becomes bound to a simple sugar. Ledochowski et al. theorized that malabsorbed 
fructose results in a fructose-L-tryptophan complex, which is then lost in excretion.  
Based on this theory, a diet high in multiple, poorly absorbed CHOs such as a high-
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FODMAP diet, may lead to reduced levels of the bioavailability of tryptophan and 
possibly impact mood perception however, proof of concept studies are needed. 
6.   Conclusion 
 Irritable Bowel Syndrome (IBS) is the most commonly diagnosed 
Gastrointestinal (GI) condition in the United States 
48
. In 2012, it was estimated that 10% 
of Americans meet the diagnosable criteria for IBS, translating to 30 million people 
48
. 
IBS is an umbrella term that incorporates a spectrum of chronic or recurrent symptoms 
including abdominal pain, bloating, distension, excessive wind and altered bowel habits 
when anatomical abnormalities and inflammation have been excluded 
12
. A low-
FODMAP diet is now considered an effective strategy for managing symptoms of IBS in 
Australia, with interest expanding across the world 
12
. FODMAPs’ ability to increase GI 
symptoms are centered around FODMAPs’ three common functional properties; They are 
1) poorly absorbed in the proximal small intestine, allowing substrate to reach the distal 
small intestine and proximal colon 2) small and osmotically-active, which increases the 
liquidity of luminal content due to osmosis and 3) rapidly fermented by gut microbiota, 
increasing the amount of gas present in the colon. Dietary adherence is crucial to the 
success of a low-FODMAP diet, however most people do not find the diet easy to 
incorporate into their life 
8,10
. Several limitations of a low-FODMAP diet pertaining to 
dietary quality and health benefits have been suggested. Malabsorbed FODMAPs provide 
multiple benefits including a natural laxative effect due to their osmotic effects, a 
prebiotic effect with beneficial fermentation by-products 
12
 and production of  a low 
glycemic response compared to other CHO 
21
. Additionally malabsorption of certain 
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FODMAPs has been linked to increases in undesirable mood states 
98-100
. Not one study 
has looked exclusively at healthy adults, changes in intake or looked at overall diet 
quality as compared to established guidelines. A study is needed looking at dietary 
quality of low- vs. high-FODMAP diets and should consider adherence and other factors 
that may influence efficacy and potential impact of the diet. 
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Appendix B 
Methods 
 
Study Design  
 The study was done by the Energy Balance Lab (EBL) at The University of 
Rhode Island (URI) in the spring/summer 2013. It was a randomized, single-blinded, 
cross-over study comparing two dietary conditions in a free-living setting; a low-
FODMAP and a high-FODMAP diet. In order to ensure that the diet was single-blinded, 
the study was entitled “The Carb Study” and the two conditions were labeled “Diet 1” 
and “Diet 2” representing the low-FODMAP and high-FODMAP diets respectfully. The 
diet instruction booklet that corresponded to each dietary condition was developed 
specifically for this project based on multiple published articles 
1,5,23,24
. The selection 
process was randomized, with a coin flip determining which group the first participant 
would begin. Each of the two conditions lasted 3 days: Tuesday, Wednesday, and 
Thursday.  An eleven day wash out period where subjects consumed their normal diet 
separated the two conditions. The subjects had baseline measurements and measurements 
after completing each diet measured on Tuesday and Friday mornings after a 10 hour 
fast. In total, there were five visits: an initial assessment (visit 1), two baseline testing 
(visit 2 & 4), two post-diet testing (visits 3 & 5).  
 
Recruitment  
 The majority of the subjects were recruited from a list of “Potential Study 
Volunteers” comprised of adults who were candidates or participants in previous, 
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nutrition-related studies and expressed a desire to be contacted for future studies. A mass 
email was sent from the EBL team to any adult on this list. In addition to this list, 
classroom announcements were made in three nutrition classes made up of primarily 
nutrition students or students in other health-related fields. The estimated attrition rate 
was expected to be low and was based on a study done by Dr. Melanson (The PI) with a 
similar demographic and study design (25). In total, 20 participants began the 
intervention, the attrition rate was 20% and the final sample size was 16. Of the four who 
did not complete, one subject dropped out due to a hospitalization that involved antibiotic 
treatment and three subjects did not report to the lab for an appointment.    
 
Subjects 
 Overall, 18 healthy subjects, free of any gastrointestinal illness completed the 
study. Gastrointestinal illness included celiac disease, IBS, lactose or gluten intolerance, 
diverticular disease, colitis such as Crohn’s disease or ulcerative colitis or stomach ulcers. 
Additional exclusion criteria included any food allergies, being a current smoker, being 
on a weight loss diet, pregnant or lactating, type 1 or 2 diabetes, adrenal disease, kidney 
or bladder problems a thyroid disease or currently taking any appetite suppressant 
medications.  
 
Initial Assessment/Screening 
 During visit 1, potential participants completed an initial assessment and a 
screening which assured their status as a healthy adult clear of any GI complications. 
Once subjects were declared eligible, demographic measurements and assessment of 
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body fat percentage using the BOD POD Body Composition System (Life Measurement 
Instruments, Concord, Calif., USA) was performed. BODPODs are used to estimate % 
fat via air displacement plethysmography (ADP). The procedure has been described in 
full in a previous study
105
. In brief subjects are weighed in minimal clothing. They are 
then placed in the BOD POD where measurements of body volume are made.  Once 
multiple measurements are made, if the body volume is within 150 ml, the BOD POD 
then measures thoracic lung volume. From the body mass, body volume and thoracic 
lung volume obtained, the BOD POD can then determine body density and % fat. 
 
Baseline testing: Fasting 
 During the baseline visits, subjects reported to the EBL following a 10 hour fast 
where they completed baseline measurements of height, weight, waist circumference, and 
an appetite/discomfort questionnaire. In a fasting state, breath hydrogen, capillary 
glucose and lipid profile was also collected. (Protocol regarding breath hydrogen, 
capillary glucose, lipid profile and changes in appetite are discussed in Appendix C 
however it is important to note that change in these variables are being analyzed as part 
of another student’s thesis.)The appetite/discomfort questionnaire was a 10 cm visual 
analogue scale (VAS) for subjects tor rate hunger, satiety, desire to eat and thirst. The use 
of VAS scales is considered a reliable and valid measurement of appetite 
106
.  The 
appetite/discomfort scale used is a five question, VAS-format scale that considered 
hunger, satiety, thirst and abdominal discomfort.  
 
Baseline testing: Test Meal 
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 Following these baseline measurements, subjects consumed a high-FODMAP 
test meal consisting of: two slices of whole wheat toast, one with 1 tbsp of honey and one 
with 1 tbsp of sugar free, no sugar alternative jam, 12 oz of 2% milk and 40 grams of 
raisins. The Test meal contained 1.141 grams of polyols, 28.494 grams of fructose, .661 
grams of galactose and 18.234 grams of lactose, totaling 47.86 grams of FODMAPs. The 
amount of FODMAP was determined using the 2012 version of the Nutrition Data 
System for Research (NDS-R) from the Nutrition Coordinating Center (NCC) at the 
University of Minnesota. The test meal was comprised to have approximately 50 grams 
of FODMAPs.  It is of note that NDSR, like most nutrition databases, does not quantify 
oligosacchardies such as FOS and GOS, thus, the grams of total FODMAPs is most likely 
slightly higher due to FOS commonly found in wheat. This number was based on 
standards used in breath hydrogen testing of lactose intolerance 
99
 and fructose 
intolerance 
98
.  
 
Baseline testing: Postprandial testing 
 Thirty minutes postprandial, subjects completed the same appetite/discomfort 
and repeated the same collection methods as fasting measurements described above. A 
third and final round of testing using the same procedures was conducted 60 minutes 
postprandial. The break between these three testing points was allocated to subjects  
receiving dietary instructions for their intervention, and completion of a 24-hour recall. 
The total time of these visits was approximately 75 minutes.  
 
Baseline Testing: Diet Instructions and Diet Booklet 
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 During baseline visits, subjects met with a member of the research team 
educated in the FODMAP diet who provided each subject with a16 page diet instruction 
booklet labeled either “Diet 1” or “Diet 2”. The booklets contained detailed lists of 
recommended and restricted foods. A brief, 15 minute diet explanation was also provided 
which included identifying encouraged and discouraged foods, brief tips and reiteration 
of the impotence of adhering to the diet for the purpose of the study’s success. “Diet 1” 
corresponded to the low-FODMAP diet and “Diet 2” was the high-FODMAP diet.  
 
Post-Diet Testing 
 An almost exact replica of baseline testing protocol was used for post-diet 
testing. The only addition was the addition of an “opinion regarding the diet” 6 question 
mixed VAS and free response questionnaire (Appendix D). The only exemption was that 
no dietary instructions were provided during the POST-Intervention. At the end of the 
POST-diet visit, subjects were told to either follow their normal diet (visit 3) or were 
informed that the study was completed (visit 5). The subjects received a $20 incentive on 
visit 3 and a $60 incentive on visit 5.  
 
Post-diet testing: Diet opinion 
  The diet opinion scale (Appendix D) used during the POST-Intervention was 
developed for this project and had not been used in a previous study. The questionnaire 
was developed based on a questionnaire created by Gearry et al.
10
 using items identified 
by Shepherd et al.
11
 as potential barriers to adhering to a low-FODMAP diet. Of note, 
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since the completion of this study, a questionnaire with similar items has also been used 
by De Roest et al.
8
.  
 
Additional Questionnaires 
 In addition to in-lab data collected, subjects were given three days worth of 
questionnaires assessing appetite, symptoms and mood. The appetite questionnaire used 
was the same questionnaire described earlier, however the abdominal discomfort scale 
was omitted. It was filled out pre- and post-meals, mid-afternoon, mid-evening and 
before bed, for a total of nine times throughout the day. The mood and the symptom 
questionnaires were filled out daily, before bed. The mood questionnaire used (Appendix 
D) was a non-validated VAS questionnaire developed by the EBL and used in only one 
previous study 
31
. The format was an eight question, VAS scale. The Symptoms 
questionnaire (Appendix D) was a new, 3-item, mixed VAS, yes/no and free response 
questionnaire developed by a gastroenterologist at Rhode Island Hospital that had not 
been used before in a study.  
 
Instruments and methods for answering research questions 
Dietary Quality 
 During visits 2, 3, 4 and 5, trained researchers conducted a 24 hour food recall 
corresponding to all food and beverage items consumed the previous day. The 24-hour 
food recall consisted of participants recalling every food or beverage item that they ate on 
the previous day, from midnight to midnight. Nutrition calculations were performed 
using the Nutrition System for Research (NDS-R) software version 12 developed by the 
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Nutrition Coordinating Center, University of Minnestoa, Minneapolis. NDS-R utilizes a 
multiple pass method described in full elsewhere 
26
. Briefly, pass one included obtaining 
a quick list of foods consumed in the past 24 hours. In pass two, participants are asked to 
produce details regarding foods on their quick list including portion sizes and amounts 
eaten. In pass three the list is recited and participants are asked if any information was 
forgotten.  
 Foods that were not in the NDS-R database were cited as “missing foods” and 
corrected after the interview was completed. Resolution of a missing food usually 
required finding an NDSR substitute (very similar food or a generic version of a food) in 
the database and matching that substitute for CHO, protein, fat and kcals. Matching was 
defined as within 1-3 grams for each macronutrient and within 10 kcals for energy. For 
some foods, the FODMAP content was considered too variable for a substitution (for 
example ice cream brands and gluten free products). These foods were emailed to NDSR, 
who then provided an accurate nutrient breakdown for those items.  
 
Dietary Quality: Healthy Eating Index 2010 
From this NDSR output file, a single dietary quality score entitled The Healthy Eating 
Index 2010 (HEI-2010) was obtained through calculations described in greater detail in 
Appendix E. The HEI is a measure of dietary quality determined by how well an 
individual’s diet compares with federal dietary guidelines, and based directly on the 
Dietary Guidelines for Americans (DGA) 
29
. The DGA are issued every 5 years by the 
United States Department of Agriculture (USDA) and the US Department of Health and 
Human Services 
29
. The HEI-2010 is the most up-to-date version, modified from the HEI-
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2005 and based on the release of the 2010 DGA and revised USDA Food Patterns 
29
. The 
actual score computed was a single number ranging from 0-100 with higher numbers 
representing better rated diets. The categories considered included total fruit, whole fruit, 
total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and 
plant proteins, fatty acids, refined grains, sodium, and empty calories 
29
. The change in 
HEI-2010 score from PRE-, to POST-Intervention was used to define change in dietary 
quality score. 
 
Dietary Adherence 
NDS-R output files were used to sum total intake (g) of fructose, lactose and the sugar 
alcohols (erythritol, inositol, isomalt, lactitol, maltitol, mannitol, pinitol, sorbitol and 
xylitol.) These items were used to define FODMAP intake. It is important to note that 
because NDS-R (as well as most other nutrition database systems) cannot calculate 
consumption of GOS or FOS, this number obtained does not translate to total FODMAP 
intake. Dietary adherence therefore, was defined according to available FODMAP items.  
Adherence to the low-FODMAP diet was defined as a reduction of FODMAP from 
baseline to day three of each diet. Adherence to the high-FODMAP diet was defined as 
an increase in FODMAP from baseline to day three of the diet. There are currently no set 
values to define high or low-FODMAP diets  
 
Comparing Mood with FODMAP Intake, Symptoms and Breath Hydrogen 
 As mentioned previously, mood and symptom questionnaires were obtained for 
each day of the 3 day intervention. Participants completed these questionnaires at night, 
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just prior to bed. The scores of interest were the scores obtained on the third day of the 
intervention. FODMAP intake for that same day was reflected on the 24 hour food recall 
obtained during the Post-Diet testing. This allowed for comparison of participants’ mood 
scores to 1) their intake of FODMAP, 2) their reported symptoms 3) their HEI-2010 
scores on the same day and at the end of the three day intervention. Appendix F show 
questionnaire data from mod variables that did not make it into the manuscript results.  
 
Statistics 
This was a secondary data analysis from a larger study powered on blood glucose. 
Statistical analyses were performed using SPSS (v22). All variables met criteria for 
normality.  Baseline comparisons between subjects assigned to the two orders were 
conducted using t-tests and Χ2 tests.  Primary outcomes (grams FODMAP and HEI-2010 
scores) were assessed using separate 2 (treatment) x 2 (time) x 2 (order) mixed factorial 
ANOVA followed by within-treatment paired t-tests (baseline and intervention). Eta
2 
was 
calculated to estimate effect size using Cohen’s categories of small (.1), medium (.6) and 
large (.14)
32
. Energy intake (kcal/day) was assessed using similar analyses.  All other 
inferential analyses of dietary components were performed using a 2 x2 repeated 
measures ANOVA where the independent variables were treatment (low- vs. high-
FODMAP) and time (baseline vs. intervention). Paired t-tests compared mood, symptoms 
and compliance factors between treatments and Pearsons bivariate correlations explored 
relationships between variables. P value <0.05 was considered statistically significant. 
 
Required Resources 
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Department computers with NDSR and SPSS were already set up and working in the 
EBL. All necessary laboratory equipment including the Alere Cholestech LDX System 
and the Quintron Model CM Clinical Microlazer were already set up and working in the 
EBL. Food models were already available in the EBL
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Appendix C: Protocol for breath hydrogen, blood glucose and blood lipid collection 
Breath Hydrogen Collection Protocol 
Warm Up Period 
1. Turn on system 15 minutes (at least) prior to use.  
2. Following the warm up period, adjust the front panel labeled “parts per million” 
until it reads “000” 
Calibration 
  Materials needed- Reference gas, SivRite cartridge, syringe, stopcock 
1. Pull “out” valve stem so that pilot light turns GREEN 
2. Using a syringe with stopcock, extract 20 ml of reference gas (concentration of 
98 ppm).  
3. Place the SivRite cartridge directly into the flush port. 
4. Inject the reference gas into the machine via the SivRite cartridge.  (if reference 
gas cannot be injected, check to make sure A-the valve stem is pulled all the way out and 
B- the stopcock is open.) 
5. After the gas has been flushed, push the valve stem “in” until the GREEN light 
changes to RED and observe the meter response.  
6. Once the meter response becomes stable, adjust the “calibrate” knob until it 
reads “098”. 
7. Pull the valve stem “out” and the meter response should read “000”. 
8. If meter response does not read “000”, re-zero the instrument and repeat 
calibration process. 
9. Continue process until instrument is properly calibrated 
Collection of Sample: 
  Materials needed- Breath Collection kit (including mouth piece, collection 
  bag and discard bag), SivRite cartridge, syringe, stopcock 
1. Ask subject to take deep breath and hold breath for 15 seconds. 
2. After 15 second has passed, have subject exhale normally into collection bag. 
3. Label Sample bag (Subject ID and Pre or Post meal). 
Analyzing a Sample 
1. Using a syringe with stopcock, extract 20 ml of the sample gas from the 
collection bag. 
2. Pull the valve stem “out” so that the pilot light turns GREEN 
3. Connect the SivRite Cartridge to the flush port.   
4. Inject 20 ml of the sample gas into the machine via the SivRite Cartridge 
5. Push valve stem “in” until the light turns RED 
6. Record the H2 concentration (ppm) presented in the meter response 
7. Pull Valve stem “out” so that light turns GREEN and release the sample from 
the port 
8. Using the syringe, back flush 40 ml of room air into the machine. 
9. Repeat analysis using an additional 20 ml taken from the original collection bag.  
10. Take the average of the two numbers 
 This process can be done after the participant has left. Samples are good for 2-3 
hours in the breath collection bag  
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Appendix D: Questionnaires 
 
Opinion regarding the diet questionnaire 
 
SUBJECT #: ________     DATE: _________________     DIET:   1            2 
 
These questions relate to your personal opinion regarding the diet you had been asked to 
follow.  Please rate yourself by placing a small “x” across the horizontal line at the point 
which best reflects your present feelings.  
 
 
1. How easy/difficult had it been to implement the diet? 
         very easy                         very difficult 
 
 
2. How easy/difficult had it been to adhere to the diet? 
        very easy                   very difficult 
   
 
3. How easy/difficult was it to obtain the appropriate food? 
         very easy                                 very difficult 
  
 
4. How would you rank the overall taste? 
 
    did not like it at all                       liked it very much 
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5.    What were the biggest challenges in following this diet? 
 
 
 
 
 
 
 
6.    What did you like about this diet? 
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The Mood Questionnaire 
 
SUBJECT:.#: ________     DATE: _________________     DIET:   1            2 
 
*Please fill this once a day before bed 
These questions relate to your “mood state” at this time.  Please rate yourself by placing a 
small “x” across the horizontal line at the point which best reflects your present feelings.  
 
 
1. How alert do you feel? 
    very little            very much 
 
2. How sad do you feel? 
    very little                     very much 
 
3. How tense do you feel? 
    very little           very much 
 
4. How much of an effort is it to do anything? 
 
    very little            very much 
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5. How happy do you feel? 
  very little                    very much 
 
6. How weary do you feel? 
    very little          very much 
 
7. How calm do you feel? 
    very little                   very much 
 
8. How sleepy do you feel? 
    very little                             very much 
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The symptom questionnaire 
 
Abdominal Symptoms Questionnaire 
 
Please fill out this form every evening (preferably prior to going to bed) for each of the 3 
days prior to your next scheduled visit.   
 
 
1. A)  Are you currently suffering from any abdominal pain?     Yes   No 
 
 B) If yes, how severe is the abdominal pain? 
             No pain          Severe Pain 
  
 C) Please enter the number of days that you get the pain in every 10 days? 
  *For example, if you enter 4 it means that you get pain 4 out of every 10 
days. If                        you get pain every day, enter 10. 
  
  Number of Days with pain:       
 
 
 
2. A) Do you currently suffer from abdominal distension*?     Yes No 
       (Bloating, swollen or tight tummy) 
           (*Women, please ignore distension related to periods) 
 
B) If yes, how severe is you abdominal distension/tightness? 
 
      No distension         Very Severe 
 
3.  How satisfied are you with your Bowel Habit? 
   
 
    Un-happy     Very Happy 
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Appendix E: Calculating the Healthy Eating Index 2010 (HEI-2010) 
 
 
Calculation for the HEI-2010 was based off of a protocol developed by the Nutrition 
Coordinating Center (NCC) at the University of Minnesota based off of methods 
described in a previous study_ENREF_106
30
. It is important to note that it is only 
possible to estimate an approximation of the HEI-2010 score using NDSR.  
 
Steps: 
 
Step one of calculating the total HEI-2010, involved calculating each of the individual 
index components. Step two included taking that number and conforming it to the unit of 
measure used in the index (such as servings converted to cups). Step three involved 
comparing intake of each item to the score rubric (table 1). Step 4 involves summing the 
individual scores to produce a single HEI-2010 score. Two decimal points were used for 
every spot. 
 
 
Table 4: Healthy Eating Index-2010 components and standards for scoring 
Component  Optimum 
Score  
Standard for maximum 
score  
Standard for 
minimum score of 
zero  
Total Fruita 5  ≥0.8 cup eq/1,000 kcal  No fruit  
Whole Fruitb  5  ≥0.4 cup eq/1,000 kcal  No whole fruit  
Total Vegetablesc  5  ≥1.1 cup eq/1,000 kcal  No vegetables  
Greens and Beansc  5  ≥0.2 cup eq/1,000 kcal  No dark-green 
vegetables or beans or 
peas  
Whole Grains  10  ≥1.5 oz eq/1,000 kcal  No whole grains  
Dairyd  10  ≥1.3 cup eq/1,000 kcal  No dairy  
Total Protein Foodse  5  ≥2.5 oz eq/1,000 kcal  No protein foods  
Seafood and Plant 
Proteinsef  
5  ≥0.8 oz eq/1,000 kcal  No seafood or plant 
proteins  
Fatty Acidsg  10  (PUFAs+MUFAs)/SFAs >2.5  (PUFAs+MUFAs)/SF
As ≤1.2  
Refined Grains  10  ≤1.8 oz eq/1,000 kcal  ≥4.3 oz eq/1,000 kcal  
Sodium  10  ≤1.1 gram/1,000 kcal  ≥2.0 grams/1,000 kcal  
Empty Caloriesh  20  ≤19% of energy  ≥50% of energy  
 
a Includes 100% fruit juice.  
b Includes all forms except fruit juice.  
c Includes any beans and peas not counted as Total Protein Foods.  
d Includes all milk products, such as fluid milk, yogurt, cheese, and fortified soy 
beverages.  
e Beans and peas are included here (and not with vegetables) when the Total 
Protein Foods standard is otherwise not met.  
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f Includes seafood, nuts, seeds, soy products (other than beverages) as well as 
beans and peas counted as Total Protein Foods.  
g Includes seafood, nuts, seeds, soy products (other than beverages) as well as 
beans and peas counted as Total Protein Foods.  
h Calories from solid fats, alcohol, and added sugars; threshold for counting 
alcohol is >13 g/1000 kcal.  
© 2013 Regents of the University of Minnesota. All rights reserved 
 
 
Calculation based on individual index component:  
 
Total Fruit 
 
1. The following items were extracted from output file 9 from NDSR and summed 
up to give total fruit (servings): Citrus juice, fruit juice excluding citrus juice, citrus fruit, 
fruit excluding citrus fruit, avocado and similar, fried fruits and fruit-based savory snacks 
2. Total fruit (serving) was than divided by two to produce total fruit (cups) 
3. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
4. Then total fruit (cups) was divided by the results of step 3 
5. The result of step 2 was then multiplied by the optimum total fruit score (5) and 
divided by the standard for maximum total fruit score (.8) to yield the total fruit score. A 
maximum of 5 and minimum of 0 was used 
 
Whole Fruit 
 
1. The following items were extracted from output file 9 from NDSR and summed 
up to give whole fruit (servings): citrus fruit, fruit excluding citrus fruit, avocado and 
similar, fried fruits and fruit-based savory snacks 
2. Whole fruit (serving) was than divided by 2 to produce total fruit (cups) 
3. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000 
4. Whole fruit (cups) was divided by the results of step 3 
5. The result of step 2 was then multiplied by the optimum whole fruit score (5) 
and divided by the standard for maximum whole fruit score (.4) to yield the whole fruit 
score. A maximum of 5 and minimum of 0 was used 
 
Total Vegetables 
 
1. The following items were unconditionally extracted from output file 9 from 
NDSR and summed up to produce total vegetables (servings): Dark-green vegetables, 
deep yellow vegetables, tomato, white potatoes, fried potato, other starchy vegetables, 
other vegetables, friend vegetables and vegetable juice. 
2. Legumes (cooked dried beans) was extracted and added to the total vegetable 
component score only if the “total protein foods” (including legumes (cooked dried 
beans)) max score (>2.5 oz eq/1000 kcals) was reached.  
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3. Total vegetables (serving) was than divided by 2 to produce total vegetables 
(cups) 
4. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
5. Then total vegetables (cups) was divided by the results of step 4 
6. The result of step 3 was then multiplied by the optimum total vegetable score 
(5) and divided by the standard for maximum total vegetable score (1.1) to yield the total 
vegetable score. A maximum of 5 and minimum of 0 was used 
 
Greens and Beans 
 
1. Dark green vegetables (servings) from output 09 was extracted and used as the 
greens and beans score 
2. Legumes (cooked dried beans) was extracted and added to the total vegetable 
component score only if the “total protein foods” (including legumes (cooked dried 
beans)) max score (>2.5 oz eq/1000 kcals) was reached.  
3. Greens and beans (serving) was than divided by 2 to produce greens and beans 
(cups) 
4. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
5. Then greens and beans (cups) was divided by the results of step 4 
6. The result of step 3 was then multiplied by the optimum total vegetable score 
(5) and divided by the standard for maximum total vegetable score (.2) to yield the total 
vegetable score. A maximum of 5 and minimum of 0 was used 
 
Whole Grains 
 
1. The following items were extracted from output file 09 from NDSR and 
summed up to produce whole grains (oz equiv): Grains, flours and dry mixes-whole 
grains, loaf-type bread and plain rolls- whole grain, other bread (quick breads, corn 
muffin, tortillas)-whole grain, crackers-whole grain, pasta-whole grain, ready-to-eat 
cereal (not presweetened)-whole grain, ready-to-eat cereal (presweetened)-whole grain, 
cakes, cookies, pies, pastries, donnish, doughnuts and cobblers-whole grain, snack bars-
whole grain, snack chips-whole grains, popcorn, and flavored popcorn.    
2. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
3. The result of step 1 was then multiplied by the optimum whole grains score (10) 
and divided by the standard for maximum total vegetable score (1.5) to yield the whole 
grains score. A maximum of 10 and minimum of 0 was used. 
 
Diary 
 
1. The following items were extracted unconditionally from output file 9 from 
NDSR and summed up to give total fruit (servings): milk-whole, milk, reduced fat, milk, 
low fat and fat free, milk, nondiary, ready-to-drink flavored milk, whole, ready-to-drink 
flavored milk-reduced fat, ready-to-drink flavored milk-low fat and fat free, sweetened 
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flavored milk beverage power with non-fat dry milk, artificially sweetened flavored milk 
beverage with non-fat dry milk, cheese-full fat, cheese-reduced fat, cheese-low fat and fat 
free, cheese-nondairy, yogurt-sweetened whole milk, yogurt-sweetened low fat, yogurt-
sweetened fat free, yogurt- artificially sweetened whole milk, yogurt- artificially 
sweetened low fat, yogurt-artificially sweetened fat free, yogurt-nondairy, pudding and 
other diary deserts, artificially sweetened pudding and other diary deserts, dairy-based 
sweetened meal replacement/supplement, diary-based artificially sweetened meal 
replacement/supplement 
2. Frozen diary deserts was also obtained from output file 09, then times by three 
and added to the score obtained in step one to produce the total diary score 
3. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
4. Then total diary (cups) was divided by the results of step 3 
5. The result of step 4 was then multiplied by the optimum total diary score (10) 
and divided by the standard for maximum total fruit score (1.3 cups) to yield the diary 
score. A maximum of 10 and minimum of 0 was used 
 
Total Protein Score 
 
1. The following items were extracted unconditionally from output file 9 from 
NDSR and summed up to total protein (oz equiv): beef, lean beef, veal, lean veal, lamb, 
lean lamb, fresh pork, lean fresh pork, cured pork, lean cured pork, game, poultry, lean 
poultry, fried chicken-commercial entrée and fast food, fish-fresh and smoked, lean fish-
fresh and smoked, fried fish-commercial entrée and fast food, shellfish, fried shellfish- 
commercial entrée and fast food, cold cuts, lean cold cuts and sausage, organ meats, baby 
food meat mixtures, eggs, egg substitute, nuts and seeds, nuts and seed butters and meat 
alternative.  
2. From the NDSR output file 09, (legumes x2) was added only if the score from 
step 1 was less than <2.5 oz/1000 kcals. 
3. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
4. Then total protein score (oz) was divided by the results of step 3 
5. The result of step 4 was then multiplied by the optimum total diary score (5) and 
divided by the standard for maximum total protein score (2.5 oz) to yield the diary score. 
A maximum of 5 and minimum of 0 was used 
 
Seafood and plant protein 
 
1. The following items were extracted unconditionally from output file 9 from 
NDSR and summed up to seafood and plant protein (oz equiv): fish-fresh and smoked, 
lean fish- fresh and smoked, fried fish-commercial entrée and fast food, shellfish, fried 
shellfish- commercial entrée and fast food, nuts and seeds, nut and seed butters, meat 
alternative 
2. From the NDSR output file 09, (legumes x2) was added only if the score from 
step 1 was less than <2.5 oz/1000 kcals. 
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3. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
4. Then total protein score (oz) was divided by the results of step 3 
5. The result of step 4 was then multiplied by the optimum total diary score (5) and 
divided by the standard for maximum total protein score (.8 oz) to yield the diary score. 
A maximum of 5 and minimum of 0 was used 
 
Fatty acids 
 
1. From NDSR output file 04 the sum of all PUFAs and total MUFAs were 
extracted and added together 
2. From NDSR output 04 the sum of all SFAs were added together 
3. The result of step 1 was divided by the result of step 2 
4. The following equation was used to determine the fatty acid component score 
(result of step 3-1.2)*10/1.3. A minimum of 0 and a maximum of 10 was used 
 
Refined Grains 
 
1. The following items were extracted from output file 9 from NDSR and summed 
up to give refined grains (oz equiv):grains, flour and dry mixes-some whole grains, grain, 
flours and dry mixes-refined grain, loaf-type bread and plain rolls-some whole grain, 
loaf-type bread and plain rolls-refined grains, other bread (quick bread, corn muffins, 
tortillas)- some whole grain, other breads (quick bread, corn muffins, tortillas)-refined 
grain, crackers-some whole grains, crackers-refined grains, pasta-some whole grain, 
pasta-refined grains, ready-to-eat cereal (not presweetened)- some whole grains, ready-
to-eat cereal (not presweetened)-refined grain, ready-to-eat cereal (presweetened)-some 
whole grain, ready-to-go cereal (presweetened)-refined grain, cakes cookies, pies, 
pastries, danish, doughnuts and cobblers-some whole grain, cakes cookies, pies, pastries, 
danish, doughnuts and cobblers-refined grains, Snack bar-Some whole grain, snack bars-
refined grains, snack chips-some whole grains, snack chips-refined grains, baby food 
grain mixtures-refined grains 
2. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
3. Then total protein score (oz) was divided by the results of step 3 
4. The following formula was then applied =2.5-((the result of step 3)-1.8).  
5. The following formula was then used to yield the final refined grain score ((the 
result of step 5)*10/2.5). A minimum of 0 and maximum of 10 was used. 
 
Sodium 
 
1. The total amount of sodium (mg) extracted from output 09 from NDSR was 
obtained and multiplied by 1000 to yield sodium in g 
2. Total energy expenditure (taking from NDSR output file 04) was first divided 
by 1000.  
3. The following formula was then applied =.9-((result of step 2)-1.1) 
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4. The following formula was then used to yield the final refined grain ((result of 
step 3)*10/0.9) a minimum of 0 and a maximum of 10 was used 
 
Empty calories 
 
1. From NDSR output file 04: 
a. Saturated fat (g) x 9 kcals/gram=kcals from saturated fat 
b. Total trans fat (g) x 9 kcal/gram= kcal from trans fat 
c. Added sugar (by total sugar (g)) x 4 kcal/gram=kcal from added sugar 
2. From NDSR output file 04, alcohol consumption was determined by the 
following steps: 
a. Total daily energy intake (kcals) X 0.013 (g/kcal allowable alcohol)= allowable 
alcohol (g) 
b. If alcohol (g) is > than allowable alcohol (g), then: 
i. [alcohol (g) – allowable alcohol (g)] x 7 kcal/g = kcal from excess alcohol 
3. Sum the results of 1-a,-b,-c and 2-b-i 
4. Based on the total energy intake from output file 04, the following equation was 
used 
a. [kcals from empty calories/total kcals] X 100 = % energy from empty calories 
5. Then, the following equation was used: 100-(result of step 4-a) 
6. The following formula was then used to yield the final empty calorie score: 
((the result of step 5-50))*20/31. A minimum of 0 and a minimum of 20 was used 
 
Calculating the total HEI-2010 
1. The results of each individual component scores was added together to yield the 
HEI-2010 
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Appendix F: Tables & Other Results 
 
Table 5: Differences in mood and GI distress scores between the low and high-
FODMAP diet (n=16) 
 
Low-
FODMAP 
High-
FODMAP  Δ t 
Alert 4.44±2.51 6.03±2.80 -1.58 -1.904 
Sad 2.46±2.14 4.14±3.44 0.32 0.740 
Tense 4.14±2.57 3.44±2.46 0.71 0.937 
Effort Needed 4.73±2.59 4.04±2.52 0.69 1.437 
Happy 6.19±1.76 6.55±1.68 -0.36 0.621 
Weary 5.86±3.01 3.88±2.61 1.98 2.894* 
Calm 5.49±2.38 5.68±2.31 -0.19 -.241 
Sleepy 7.00±2.23 6.74±1.98 0.27 .469 
Ab. Pain .61±1.40 .31±.99 0.3 .885 
Ab. Distention .98±1.86 .58±1.86 0.39 .573 
Satis. With BM 6.23±1.56 6.36±2.44 -0.08 0.889 
*=p<.05 
Differences between low- and high-FODMAP diet compared using a Paired ttest 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Alert Sad Tense Effort needed Happy Weary Calm Sleepy Abd Pain Abd Distention Satis. With BM 
FODMAP intake .487** .098 -.284 .005 .274 -.269 .050 -.243 -.186 -.116 .165 
HEI-2010 -.204 .276 .297 .211 -.363* .222 -.151 .314 -.214 .006 -.048 
Total Calories (kcal) .357* -.036 -.257 -.096 .224 -.081 .193 -.196 -.047 .078 -.054 
Total Fat (g) .427* -.075 -.400* -.288 .125 -.306 .138 -.338 -.180 .042 -.095 
% Cal from fat .121 -.066 -.345 -.368* -.109 -.448 .033 -.254 -.197 -.089 -.170 
Total Protein (g) .226 .203 -.126 .027 -.196 .022 -.189 -.070 -.230 .166 .016 
% Cal From Protein -.113 .345 .176 .155 -.623** .139 -.531** .215 -.212 .033 .161 
Total CHO (g) .313 -.078 -.201 -.007 .344 .029 .300 -.081 .004 .073 .028 
% Cal From CHO .022 -.107 .145 .221 .393* .282 .235 .153 .192 .109 .134 
Starch (g) .160 -.100 -.178 .028 .296 .084 .290 .104 .052 .123 -.005 
Total Fiber (g) .189 .064 -.172 .081 .057 .139 .314 .080 -.189 .052 -.022 
Total Sugar .381* -.071 -.156 -.070 .319 -.049 .205 -.257 -.025 -.030 .098 
Glucose (g) .473** -.056 -.356* .106 .376* .086 .350 -.238 -.116 .048 .270 
lactose (g) .390* -.020 -.217 -.125 .169 -.437* -.223 -.067 -.168 -.147 .086 
Fructose (g) .314 .118 -.201 .090 .214 .021 .235 -.253 -.088 -.005 .145 
total sugar (g) .381* -.071 -.156 -.070 .320 -.048 .203 -.256 -.025 -.030 .098 
Added Sugars .288 -.100 -.122 -.159 .237 -.010 .180 -.323 .020 .041 .033 
glycemic Index .040 -.087 .111 .202 .194 .385* -.120 -.030 .296 .445* .095 
Caffeine .252 -.295 -.435* -.388* .171 -.142 .333 -.376* -.200 .244 -.159 
Abd. Pain -.384* -.032 .352 .234 -.002 .377* -.142 .193 
  
  
Abd. Distention -.093 .051 .065 .019 -.209 .212 .016 .124 
  
  
Satis. With BM .008 .022 .030 .459** .115 .382* -.084 .286       
Tables 6:  The correlation between selected nutrients, mood score and GI score 
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  Low-FODMAP diet High-FODMAP diet 
ANOVAa 
HEI Component Baseline Day 3 Δ Baseline Day 3 Δ F (1,15) η2 
Total Fruit (cups) 0.77±1.02 .93±.88 0.17 .93±1.15 .75±.60 -0.18 0.51 - 
Whole Fruit (cups) .62±.78 .79±.83 0.17 .65±.77 .45±.43 -0.19 1.34 - 
Total Vegetable (cups) 1.50±1.41 1.75±1.40 0.25 1.65±1.19 1.13±1.07 -0.52 1.82 - 
Greens & Beans (cups) .21±.59 .40±.57 0.19 .45±.75 .29±.47 -0.17 2.22 - 
Whole Grain (oz) 2.07±3.55 1.16±1.33 0.9 2.01±3.15 1.94±2.23 -0.07 0.72 - 
Dairy (cups) 2.29±1.67 1.11±1.29 -1.18 2.85±3.44 3.16±3.30 0.3 2.01 - 
Total Protein (oz) 4.88±4.99 7.08±5.98 2.19 4.80±4.52 6.06±4.93 1.26 0.15 - 
Seafood & Plant (oz) 1.20±2.85 1.49±2.14 0.29 1.99±3.12 1.27±2.86 -0.72 0.37 - 
Refined Grain (oz) 6.47±4.65 2.79±3.46 -3.67** 5.59±4.62 7.20±4.63 -1.61 10.562** .41 
Empty calories (kcals) 620.02±455.62 342.08±283.96 -277.94* 552.56±445.97 610.49±411.47 57.93 8.02* .35 
*=P<.05, **=P<.01 
      
  A 2 (treatment) X 2 (time) repeated measures ANOVA with post hoc ttest was used. 
  
  a= the time*treatment interaction F statistic reported 
    
  
Table 7: Healthy Eating index-2010 raw numbers (unadjusted per 1000 kcal) 
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*p<.05
Correlation Coefficients (n=15-16) 
                                           FODMAP Intake                                                                            FODMAP Intake 
  
Low- 
FODMAP 
High-
FODMAP   
Low-
FODMAP 
High-
FODMAP 
Mood variable 
 
HEI- 2010 variable 
 Alert .343 .497 Total Fruit Score .089 -.241 
Sad .305 -.014 Whole Fruit Score -.100 -.205 
Tense -.218 -.285 Total Vegetable Score .303 .187 
Effort needed .189 -.054 Greens and Beans Score .070 -.023 
Happy .159 .423 Whole Grain Score -.171 -.296 
Weary -.068 -.282 Dairy Score .106 .532* 
Calm .310 -.337 Total Protein Score -.220 -.328 
Sleepy -.311 -.163 Seafood & Plant Score .370 -.362 
   
Fatty Acid Score .296 .490 
   
Refined Grain Score -.054 -.016 
   
Sodium Score -.228 -.363 
      Empty Calorie Score -.221 -.420 
      Total HEI-2010 -.023 -.554* 
Table 8: Correlation between FODMAP intake, mood scores  and HEI-2010 scores 
7
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Additional Questionnaire Results: Opinions regarding the diet 
After completion of each diet, Random subjects (low-FODMAP n=9, high-FODMAP 
n=7) completed a 10 cm VAS scale regarding their opinion of the diet. The median score 
for “How easy/difficult had it been to implement the diet? “ (0=very easy, 10=very 
difficult) were higher (more difficult) for the low FODMAP diet (median response 6.4, 
SD= 2.1, range 0.9-8.0, interquartile range 2.1) compared to the high-FODMAP diet 
(median response 4.8, SD=2.8, range 1.1-8.3, interquartile range=3.4). The median score 
for the question “How easy/difficult had it been to adhere to the diet?” (0=very easy, 
10=very difficult) was higher for the low-FODMAP diet (median responds 5.7, SD= 1.9, 
range 1.2-7.8, interquartile range= 1.9) compared to the high-FODMAP diet (median 
responds 4.6, SD= 2.4, range 0.8-7.3, interquartile range= 4.7). The median score for the 
question “How easy/difficult was it to obtain the appropriate food?” (0=very easy, 
10=very difficult) was lower (easier) for the low-FODMAP diet (median responds 2.5, 
SD= 1.7, range 1.2-5.8, interquartile range 3.2) compared to the high-FODMAP diet 
(median responds 4.5, SD= 2.3, range .9-5.9, interquartile range 4.7). Median scores for 
the question “How would you rank the overall taste?” (0=did not like it at all, 10=liked it 
very much) were lower for the low-FODMAP diet (median score 4.6, SD= 2.4, range 0-
8.0, interquartile range 2.2) compared to the high-FODMAP diet (median scores 7.0, 
SD= 1.5, range 4.7-8.9, interquartile range 2.6).  
 Two free response questions were also included on the questionnaire.  For the 
question “What were the biggest challenges in following this diet?” responses for the 
low-FODMAP diet included: 1)lack of variety, 2)changing from his/her normal diet 
(n=2), 3) food availability, 4)restriction of milk and apples, 6)lack of options in school 
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dining hall, 6)unable to use sweeteners and 7)having to pay close attention to foods eaten. 
For the question, “What did you like about this diet?” responses from the low-FODMAP 
diet included 1)trying different foods (2), 2)increasing fruits (1) and vegetables (2), 3) 
realizing how many carbohydrates he/she consumes, 4) enjoyed options (did not specify 
if this means as compared to the high-FODMAP diet and 5) enjoyed the high fiber foods 
and eliminating old foods. For the high-FODMAP diet, reported challenges include 1) 
changing from normal diet, 2) not eating rice, 3) wanting food not offered on the diet. For 
“what did you like about this diet?”, responses on the high-FODMAP diet include 
1)realizing what I eat, 2)able to eat pasta, 3)easier to follow (than the low-FODMAP 
diet).  
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Appendix G. Diet Instruction Booklets 
Low-FODMAP diet (Diet 1)
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High-FODMAP diet (diet 2) 
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